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ABSTRACT
Natural Killer (NK) cells are abundant in pregnancy and contribute to the health of the
fetus. Uterine NK (uNK) cells provide less cytotoxic function than their conventional NK (cNK)
cell counterparts. Various combinations of Killer Immunoglobulin Receptor (KIR)- Human
Leukocyte Antigen (HLA) on maternal NK and fetally derived cells, respectively, can have
different effects on the health of pregnancy in humans. Murine NK cells contain Ly49 receptors,
an equivalent to KIRs. Therefore, Ly49 receptor interactions with fetally-derived MHC-I
molecules can be a valuable model for studying the role of NK cells in pregnancy. The process
of spiral artery remodeling can indicate the health of a pregnancy, as it allows for placental
perfusion and increased blood flow to the fetus. Previous studies have shown that allogeneic
MHC molecules produce suboptimal spiral artery remodeling, a process characterized by
reduced interferon gamma (IFN-γ) production and decreased fetal weights. Ly49 knockout mice
have been derived on a B6 background. Litters from these mice have decreased fetal weights
especially when fetally derived cells carry foreign MHC molecules. Ly49 knockout mice have
defects in IFN-γ production and spiral artery remodeling, indicating that Ly49 receptors on NK
cells at the maternal-fetal interface are important for the production of IFN-γ that is necessary for
spiral artery remodeling. Understanding of the mechanisms used by Ly49 receptors on uNK cells
during pregnancy will allow for the potential discovery of therapeutics for women with high-risk
pregnancies such as recurrent miscarriage and preeclampsia.
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CHAPTER ONE
INTRODUCTION
Natural Killer (NK) cells are now members of a large growing family of cells called
innate lymphoid cells (ILCs). Conventional NK cells (cNK) are most common throughout
circulation, are derived in the bone marrow, and are well studied in the spleen and peripheral
blood. cNK cells, as their name implies, most commonly carry out cytotoxic functions and were
first discovered to spontaneously eliminate tumor cells without prior sensitization (Kärre et al.
1986). The missing-self hypothesis, proposed by Kärre and colleagues, describes NK cellmediated lysis, as it states that NK cells target cells that do not express major histocompatibility
complex (MHC) class I molecules on their surface. Conventional NK cells contain Ly49
receptors, a family of lectin-like receptors that are either inhibitory or activating to the natural
killer cell. One NK cell can express multiple Ly49 receptors at the same time, and Ly49
receptors are stochastically expressed during cNK development. The inhibitory Ly49 receptors
recognize and interact with MHC-I molecules. More specifically, Yokoyama and colleagues
found that Ly49A interacts with the MHC-I molecule H2-Dd, providing a molecular basis of
target cell recognition in the missing-self hypothesis. The inhibitory receptors expressed on NK
cells interact with self-derived MHC-I molecules and inhibit the cytotoxic properties of the NK
cell. Hence, NK cell activation by cellular targets is dependent upon integrating signals from
activation and inhibitory receptors.
NK cell receptors engage MHC-I molecules, an interaction that regulates their function.
Ly49 receptors on murine NK cells are functionally equivalent to killer immunoglobulin-like
1
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receptors (KIRs) on human NK cells, and MHC molecules in humans are referred to as human
leukocyte antigen (HLA) molecules. KIRs and their various interactions with HLA molecules in
human pregnancy have been found to impact the health of the fetus and the outcome of the
pregnancy. Genetic changes in KIR domains lead to some demographics, specifically those of
African descent, having higher risk pregnancies such as preeclampsia (Nakimuli et al. 2014).
Additionally, certain combinations of KIR-HLA in human pregnancies have been discovered as
higher risk for preeclampsia and recurrent miscarriage than others, specifically mothers with
limited activating KIRAA receptors when the fetus carries HLA-C2 on their cell surface (Hiby et
al. 2004, 2010). Since uNK cells are abundant in both human and mouse pregnancies, the mouse
model is ideal for studying Ly49-MHC-I interactions, avoiding limitations in human studies. The
mouse model also allows for genetic modifications to be made for more controlled and specific
conclusions.
Recently, tissue-resident NK cells (trNK) and innate lymphoid cell 1s (ILC1s) were
discovered in the murine virgin endometrium and in pregnancy (Sojka et al. 2014, 2018). These
sub-classes of NK-like cells are less characterized than cNK cells. Sojka et al. found that in
parabiosis studies both the trNK cells and ILC1s do not circulate but remain resident in the
uterine tissue. trNK cells are similar to cNK cells in that they both express the transcription
factor eomes, and trNK cells and ILC1s both express the integrin CD49a on their surface. trNK
cells and ILC1s exhibit less cytotoxic properties than cNK cells and are involved in cytokine,
growth factor, and pro-angiogenic factor secretion (Fu et al. 2017, Pawlak. et al. 2019).
However, their Ly49 repertoire has not yet been fully characterized. No study currently exists
that characterizes the importance of Ly49 receptors in the uterus and in pregnancy. Such studies
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will be important due to the high volume of NK cells in close proximity to the invading
trophoblast cells in the uterus during pregnancy.
Uterine Natural Killer (uNK) cells are the immune cells that dominate the maternal-fetal
interface during pregnancy both in humans and mice. uNK cells have classically been defined
histologically by periodic acid Schiff (PAS) and Dolichos bifluorus agglutinin (DBA) stains and
found to accumulate in the decidua basalis and aid in spiral artery remodeling of the placenta
(Ashkar et al. 2000). Here we define “uNK” cells to include all NK cells found at the maternalfetal interface in murine pregnancy. We can now appreciate that various subsets of NK-like cells
are present at the maternal-fetal interface.
The maternal-fetal interface in mice is comprised of the mesometrial lymphoid aggregate
of pregnancy (MLAp), the decidua basalis, a structure formed from transformed endometrial
tissue, and the fetally-derived placenta. In mice that lack cNK cells, the spiral artery remodeling
in the placenta is less optimal, resulting in growth restricted pups (Boulenouar et al. 2016).
Recently, during early pregnancy, the trNK cells were found to expand and proliferate locally
with minimal contribution from the cNK cells (Sojka et al. 2018). It is currently unknown which
sub-population of NK-like cells in the uterus are responsible for remodeling the placental
vasculature during pregnancy.
In a recent study, B6 dams were mated with D8 sires. D8 mice are B6 mice that are
transgenic for H2-Dd expressed on extravillous trophoblast cells (EVTs), exposing the maternal
uNK cells to a paternal MHC-I molecule. The dams exposed to the foreign MHC-I molecule
gave birth to growth-restricted fetal pups that had compromised vascular remodeling as
compared to the dams mated with B6 sires (Kieckbush et al. 2014). Although this study
demonstrated maternal MHC-I dependent suppression of NK cell activity, the requirement of
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Ly49 receptors was not investigated. Additionally, more recent studies point towards maternal
MHC-I being more important than paternal MHC-I when it comes to tolerance of the fetus, as
dams lacking MHC-I had growth restricted pups. The more recent study from the same group
reported that maternal uNK cells do not target fetally-derived cells that lack self-MHC
(Depierreux et al. 2022). Taken together, maternal uNK cells do not respond to missing-self like
predicted.
Maternal Ly49 receptors have previously been knocked down in female B6 mice. Spiral
artery remodeling was reduced in such pregnancies (Lima et al. 2014). However, the NK cells in
the uteri of Ly49 knockdown mice still contain some Ly49 receptors, and the placenta of a full
knockout of the Ly49 locus has not yet been studied. Analysis of the importance of Ly49
receptors on maternal uNK cells at the maternal-fetal interface during pregnancy has not been
fully addressed. Ly49 knockout mice have now been derived on a B6 background (Parikh et al.
2020), and our preliminary data with this model show that fetal birthweights are significantly
reduced when mated with wild-type B6 males and reduced further when mated with D8KODO
males (Sojka and Yokoyama, unpublished). D8KODO males are B6 mice transgenic for H2-Dd
on a KODO background, yielding them deficient in endogenous MHC-I molecules, H2K and
H2D. This mating allows us to study the mechanism of the inhibitory Ly49A/H2Dd interaction
and its effect on murine pregnancy outcomes to be studied directly. These findings emphasize
the need to understand the importance of the Ly49/MHC-I interactions at the maternal-fetal
interface in maintaining healthy murine pregnancies and fetal growth.
One consequence of poorly remodeling spiral arteries is the birth of growth-restricted
pups. This process involves the alteration of uterine arteries in pregnancy to become high
conductance vessels, allowing for placental perfusion and nutrient exchange between the mother
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and fetus (Burton et al. 2009). Interferon gamma (IFNγ) is important for this process, since IFNγ
and IFNγRα deficient mice both have defects in spiral artery remodeling (Ashkar et al. 2000).
We hypothesized that Ly49 knockout uNK cells in pregnant mice may have defects in IFNγ
production at the maternal-fetal interface, leading to suboptimal spiral artery remodeling. We
found that Ly49 knockout mice, when mated with B6 sires, have growth-restricted pups that are
accompanied by reduced IFNγ production by their uNK cells at gd9.5 compared to Ly49KO
mice. This deficiency was accompanied by reduced spiral artery remodeling, visualized by
confocal microscopy. Our work demonstrates a correlation between Ly49 receptors and their
interactions with fetal MHC-I molecules on EVTs and their pregnancy outcome. Since Ly49
receptors are the murine equivalent to human KIR receptors, this work has important
implications for understanding the role of KIR/HLA combinations in human pregnancy
complications such as preeclampsia.

CHAPTER TWO
REVIEW OF CURRENT LITERATURE
The History of Uterine Natural Killer cells
Uterine natural killer cell discovery. The story of natural killer (NK) cells goes far
beyond the naming of “natural” killer cells by Rolf Kiessling in 1975. Large granular
lymphocytes were discovered in the early 1900s in the placenta and were termed maternal
glycogenic cells (Jenkinson 1902). The morphology of such cells and their distribution were not
described until 1925 from studies in the rat placenta (Gerard 1925). Similar cells were found in
the pregnant uterine mucosa and were labeled as maternal granulated metrial gland (GMG) cells
(Selye and McKeown 1935). The importance of GMG cells in pregnancy was studied by
multiple groups throughout the late 1900s; they were finally characterized as an immune cell that
originated in the bone marrow over 75 years after their initial description (Stewart and Peel 1977,
Steward 1983). Simultaneously, Natural Killer (NK) cells were identified based on their abilities
to kill tumor cells and cause in vivo rejection (Kiessling et al. 1975a,b). The naming of NK cells
came after numerous studies of T-cells in which unexplained natural cytotoxic reactivity
occurred in vitro towards tumor antigens but not normal cells (Rosenberg et al. 1972).
Determination that these cells were neither B nor T cells caused a necessity for a new cell name
(Herberman et al. 1975a,b). Eventually, GMG cells were renamed uterine NK (uNK) cells
because they were bone marrow derived and contain perforin much like the initially identified
NK cells (Parr et al. 1987). Contrary to the first described NK cells, uNK cells were unable to
6
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kill YAC cell targets effectively (Croy et al. 1985). They were first visualized in humans
histologically as large, granulated lymphocytes in the late secretory endometrium (Bulmer et al.
1991, King et al. 1989). uNK cells take on a granular morphology after implantation in mice,
which can be visualized by their positive staining for Periodic Acid Schiff (PAS) and Dolichos
Diflorus Agglutinin (DBA) in the decidua. DBA characterized a heterogenic uNK population in
pregnancy-derived tissues. More recently high-dimensional flow cytometry was used to further
phenotype the heterogeneity. Currently in the mouse uterus, these uNK cells are characterized
via their expression of T-bet and Eomesodermin (Eomes). Group 1 innate lymphoid cells
(ILC1s) were later discovered and categorized in the uterus based on their lack of Eomes
expression. The ILC1 cell population, in addition to tissue-resident NK (trNK) cells, was found
to express CD49a and primarily remains in the uterine tissue (Doisne et al. 2015, Boulenouar et
al. 2016, Sojka et al. 2014, Montaldo et al. 2015, Filipovic et al. 2018).
Origin of uNK cells. The origin of NK cells in the uterus is not fully known.
Transfer of hematopoietic progenitor cells leads to detectable NK cells in the endometrium and
decidua (Lysiak et al. 1992, Taylor et al. 2004). In addition, human studies show that NKcommitted precursor cells are detectable in blood and respond to the cytokines interleukin 15
(IL-15) and transforming growth factor (TGF)-ß by maturing into NK cells (Male et al. 2010).
IL-15 is expressed in the endometrium and decidua, including by the extravillous trophoblasts
(EVTs). Circulating NK cells may come to the uterus and upregulate markers that would then
classify them as uNK cells or trNK cells (Hydes et al. 2018). In contrast, tissue-resident NK cells
were discovered to proliferate in situ locally in early pregnancy (Sojka et al. 2018). This finding
suggested that uNK cells may not entirely arise from the expansion of recruited conventional NK
(cNK) cells during pregnancy.
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The two-wave hypothesis describes the possibility of two separate expansions of NK
cells in the pregnant uterus: first, tissue-resident cells proliferate locally in early pregnancy as a
result of decidualization, followed by trafficking of cNK into the uterus during placentation
(Sojka et al. 2019). The cells present in the pregnant uterus have been found to upregulate
ICAM-1 and VCAM-1 adhesion molecules on stromal cells in the decidua. Adhesion molecules
indicate that these subsets may recruit other leukocytes to the site of implantation, suggesting
that uNK cells could be involved in pregnancy-induced recruitment of leukocytes to the
maternal-fetal interface (Vacca et al. 2019). However, the developmental origin of trNK cells
and to what extent they contribute to uNK cell functions in pregnancy is not yet confirmed.
Development of uNK cells. NK cells are part of the innate lymphoid cell (ILC) family.
This family includes ILC1, ILC2, ILC3, NK, and lymphoid inducer cells (LTi) cells (Vivier et al.
2018). These cells are derived from the common lymphoid progenitor (CLP), where further
signaling via eomes and T-bet produces an NK cell precursor (NKP) while a helper ILC
precursor (ChILP) arises with exposure to PLZF (Klose et al. 2014). Differential expression of
T-bet, GATA-3, and RORγt leads ChILP cells to become ILC1, ILC2, and ILC3, respectively
(Artis et al. 2015). Full development into the different cell types within tissues is not completely
known. The developmental requirements may vary depending on the tissue that the cells arise/are
resident in.
Tissue resident ILC1 population was first discovered in the murine liver with the finding
of an immature NK cells in the mouse liver that differed from the more mature cNK cells in the
liver (Kim et al. 2002). Adoptive transfers of the immature liver NK cells showed that the cells
remained immature and undifferentiated (Daussy et al. 2014), and subsequent studies identified
T-Bet and eomesodermin to be key transcription factors that dictated separate lineages in NK cell

9
development for resident and circulating NK cells, respectively (Peng et al. 2013, Sojka et al.
2014). Innate lymphoid cells in the uterus (uILCs), including NK cells, have a unique plasticity
within the uterine tissue (Guia et al. 2020, Lim et al. 2017). Parabiosis has shown that trNK cells
and ILC1s are largely tissue resident (Gasteiger et al. 2015, Sojka et al. 2014), but ILCs can be
found in circulation as well (Dutton et al. 2019). Developmental trace studies have not been
accomplished for uterine trNK cells and ILC1s, and they are identified based on their expression
of CD49a and presence or lack of eomes, respectively. The spleen and blood contain low
numbers of ILC1s, and ILC3s can migrate from the mucosa of the intestines to lymph nodes
(Vely et al. 2016). ILC1s have been developmentally traced to the ILC family in the liver, but
such studies have not been accomplished in the uterus and present a gap in knowledge.
Functions of uNK cells. Due to the nature of discovery of natural killer cells, it was
surprising to find such cells in the uterus and in pregnancy-derived tissues such as the decidua
basalis. However, throughout the process of characterizing the cytotoxic cells, it was noted that
NK cells have a high propensity for cytokine release (Djeu et al. 1982). Cytokine secretion
implicated that NK cells were involved in far more processes of the immune system than simply
as a cytotoxic effector cells (Herberman 1982, Welsh et al. 1978a,b). Decidual stromal cells
(DSCs) have been shown to release IL-15 and CXCL14, both of which promote accumulation of
decidual natural killer (dNK) cells in pregnancy. Conventional NK cells are implicated in the
process of spiral artery remodeling (Cha et al. 2012, Croy et al. 1985), which can further impact
fetal growth. This hypothesis is supported by data from mice lacking the NFIL3 transcription
factor, and therefore cNK cells, have defects in the process of spiral artery remodeling
(Boulenouar et al. 2016). Additionally, uNK cells in pregnancy have been identified as key
players in both mice and humans for limiting fetally derived trophoblast invasion into the
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decidua basalis in a Gab3 dependent fashion (Lash et al. 2010, Sliz et al. 2019). While NK cells
at the implantation site have been linked to successful pregnancies, mechanisms behind uNK cell
help have not yet been discovered.
The Missing-Self Hypothesis and Ly49 Receptors
Kärre and Ljünggren proposed the missing self hypothesis, describing the phenomenon
that NK cells kill target cells by integrating signals from activating and inhibitory receptors
mediated by the respective ligands on tumor or virally infected cells and sensing HLA class I
expression (Ljünggren and Kärre 1990). The hypothesis was based on the notion that either the
altered expression or absence of MHC-I molecules would cause target cells to become
susceptible to attack by NK cells (Kärre 2002). Evidence for this claim came from a finding that
NK cells could kill tumor cells that had lost MHC class I expression (Kärre et al. 1986). After
this hypothesis, additional evidence arose that target cells transfected with HLA-expressing DNA
reversed the NK cell’s abilities to kill those targets and the protective effect of HLA molecules
was mapped to the α1/α2 domains (Storkus et al. 1989a, b). Additionally, transgenic H-2
expression in donor mice prevented allogeneic bone graft rejection. Class I MHC-deficient bone
marrow cells were rejected by MHC-matched NK cells, indicating a role for MHC-I/NK cell
interaction in graft acceptance and rejection (Ohlen et al. 1989, Bix et al. 1991, Yu et al. 1992). T
cells from ß2-microglobulin deficient mice (MHC-I deficient) were also susceptible to NK cell
killing, indicating that the killing by NK cells did not discriminate between immune and nonimmune cell targets (Liao et al. 1991). Different NK cell subsets that had been divided based on
cell surface marker expression, and such differences between the cell subsets also showed
differences in levels of cytotoxicity (Ciccone et al. 1990,1992). Two hypotheses arose from the
aforementioned studies: the receptor inhibition model, stating that NK cells contained a receptor
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specific for MHC class I molecules that, when bound, inhibit the NK cell, and the target
interference model hypothesized that MHC-I molecules on potential targets blocks the ability of
NK cells to interact with an activating ligand on the target cell.
Proof for the receptor inhibition model came from a study that a type II transmembrane
C-type lectin receptor, termed then Ly49 and now known as Ly49A (Yokoyama et al. 1990).
Ly49 caused decreased killing of some targets when present. Further analysis of Ly49+ cells
showed that they could not kill targets via any previously established mechanism (Karlhofer et
al. 1992). Analysis of MHC expression on targets showed that H-2d and H-2k background cells
were resistant to Ly49+ NK cells, indicating two ligands for the inhibitory Ly49 receptor. Killing
of such resistant cells was restored in the presence antibody against either Ly49 or the α1/α2
domains of Dd (Yokoyama et al. 2002). Similar receptors were then identified on human cells,
termed p58 and later changed to KIR2DL (Moretta et al. 1993). There are now many Ly49
receptors, some inhibitory towards NK cells activation, while others assist in activation (Ortaldo
and Young 2005). Ly49 receptors are receptors found primarily on NK cells and bind MHC class
I molecules in a peptide-dependent but not peptide-specific manner (Hanke et al. 1999). The
receptors bind MHC-I near the alpha1 and alpha 2 subunits (Tormo et al. 1999). Ly49 receptors
can be either activating or inhibitory towards the NK cell and are both homodimeric C-type
lectin-like membrane proteins and contain immunoreceptor tyrosine-based inhibitory motif
(ITIM) domains in their cytoplasmic tails. The acquisition of an inhibitory Ly49 receptor for
self-MHC-I is necessary for licensing of NK cells during development in order for them to avoid
a state of hyporesponsiveness (Kim et al. 2005). In contrast, activating Ly49 receptors will
activate cytokine production and cytotoxicity when interacting with its ligand. Ultimately, the
NK cell receives multiple signals at once, and the integration of such signals informs the action
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taken by the cell. Phosphorylation of the ITIM of inhibitory Ly49 receptors recruits tyrosine
phosphatases that contain SH2 domains (D’Ambrosio et al. 1995). Cross-linked activating and
inhibitory Ly49 receptor complexes enhance ITIM phosphorylation (Blery et al. 1997, Binstadt
et al. 1996). Activating Ly49 receptors transduce signals through DAP10/12, which contain
ITAMs and leads to phosphorylation of other downstream proteins in the cell, including Srcfamily tyrosine kinases (McVicar et al. 1998). There is heterogeneity in both the type of Ly49
receptors, as well as the amount of Ly49 receptors, which has evolved due to multiple insertion
and deletion events (Makrigiannis et al. 2001). The number of Ly49 genes is variable amongst
inbred mouse strains and up to six different Ly49 receptors can be expressed on one NK cell
(Ortaldo et al. 1999, Kubota et al. 1999).
Expression of Ly49 receptors begins early in NK cell development, with Ly49E being the
only receptor present on fetal NK cells and disappearing after birth. Other Ly49 receptors begin
to be expressed on NK cells 2-3 weeks after birth and become fully present once the mouse
reaches sexual maturity at 6-8 weeks old (Kim et al. 2002, Van et al. 2001, Dorfman et al. 1998).
Ly49 receptors have been implicated in the NK cell maturation process in that interactions with
their targets allows for NK cell “licensing,” a process which is characterized as a self-Ly49
receptor interacting with a self-MHC-I molecule (Kim et al. 2005). However, the mechanisms of
the NK cell education process are not fully known, while multiple hypotheses exist that involve
Ly49 receptor signaling.
Pregnancy is an exception to the self/non-self phenomenon described originally by
Medawar in 1953, albeit uNK cells contain Ly49 receptors. One such reason for decreased
cytotoxicity towards fetally-derived trophoblasts is that dNK cells have low cytotoxic potential
compared to other NK cell subsets (Kopcow et al. 2005, King et al. 1990, Siewiera et al. 2013)
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towards MHC-I deficient targets. Still, they have similar cytotoxic potential towards virally
infected decidual stromal cells. This finding demonstrates that these cells still have cytotoxic
potential, but do not exert it on fetally-derived trophoblast cells. A recent study found that
maternal MHC-I may be more important for pregnancy success than paternal, since MHCdeficient females carrying fetuses which expressed MHC-I produced growth-restricted fetuses.
The study also showed that peripheral NK cells rejected bone marrow cells missing self-MHC,
but uNK cells did not reject fetuses that miss self-MHC and the fetuses have adequate growth,
positing that pregnancy is an exception to the missing-self hypothesis (Depierreux et al. 2022).
The role of Ly49 receptors on uNK cells in pregnancy, however, has not been fully addressed.
The uterus and pregnancy may expose NK cells to a cytokine environment that changes the
projectory of NK cell function whilst they maintain their cytotoxic potential in case of infection.
MHC-I molecules on human cells are referred to as Human Leukocyte Antigen (HLA).
Human EVT are negative for HLA-A and B but express polymorphic HLA-C and oligomorphic
HLA-E and HLA-G (Apps et al. 2009). They are also always negative for MHC-II. Murine
trophoblast from C57BL/6 mice express MHC I H-2Kb but low levels of H-2Db and Qa-1b. The
Killer Immunoglobulin-like Receptor (KIR) family is the functional equivalent to Ly49 receptors
on human NK cells that recognize the polymorphic MHC molecules. (Huhn et al. 2021). Certain
combinations of fetal HLA and maternal KIR in humans have been shown to create more
adverse outcomes than others (Hiby et al. 2004, 2010, Larsen 2019). For example, women with
two KIR A haplotypes that is carrying a fetus that carries HLA-C2 increases the risk of that
pregnancy for defective placentation, preeclampsia, and fetal growth restriction (Hiby et al.
2014, Moffett et al. 2017, Gaynor and Colucci 2017). This is due to the strong inhibitory signal
that HLA-C2 haplotype sends through KIR A receptors on maternal dNK cells.
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Certain KIR receptors are more prevalent in some demographics than others, indicating
that some populations are at higher risk than others for negative pregnancy outcomes, especially
pre-eclampsia (Nakimuli et al. 2015). CD39 (ectonucleotide) was found to be expressed by
dNK1, which could combine with CD73 on EVT to convert ATP to adenosine. Adenosine is
known to be associated with local immune suppression, indicating that dNK cells are important
for reducing immune responses to allogenic fetal cells (Vento-Tormo et al. 2018, Strunz et al.
2021). dNK that express an activating KIR receptor were more cytotoxic against infected
decidual stromal cells than dNK lacking that activating receptor (Crespo et al. 2016, Siewiera et
al. 2013). Such studies express the importance for KIR/HLA interactions in healthy human
pregnancies. Since trophoblast cells are spared regarding the missing-self hypothesis, it is
unknown how the missing-self hypothesis is regulated in pregnancy.
Anatomy of the Uterus- Adaptation to Pregnancy
Anatomy of the implantation site. Implantation refers to the process of embryo
attachment to the endometrial surface of the uterus. The trophectoderm layer of the blastocyst
gives rise to trophoblast cells and embryos in human pregnancy (Silva et al. 2016). Various types
of trophoblast cells, which vary between species, make up the outermost layer and most of the
placenta. They also enclose the chorioamniotic membranes that enclose the amniotic cavity
(Moffett et al. 2006, Maltepe et al. 2010). A non-pregnant uterus is comprised of three layers: a
serous layer surrounds the myometrium (thick smooth muscle that contracts during labor to expel
the conceptus), and the endometrium (the layer that gives rise to the decidua). The endometrium
is ultimately a dense stroma that contains unremodeled spiral arteries. Once decidualization
occurs, the decidua can serve as an anchor point for the placenta and contains remodeled spiral
arteries that will allow for placental perfusion and enhances fetal growth.
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In mice, the endometrium is the layer that is receptive to implantation. This process
causes an endocrine cascade that causes the ovaries to release large amounts of progesterone to
foster a healthy pregnancy. Implantation occurs around gestational day 4.5. Throughout the
process of decidualization (discussed below), the decidua basalis (DB) forms, which is rich in
uNK cells. The trophoblast cells expand towards the mesometrial side of the uterus near the
uterine blood supply. Between gd8.5 and late pregnancy, the myometrial lymphoid aggregate of
pregnancy (MLAp) forms, which is a dense lymphoid structure full of uNK cells and is
embedded in the uterine wall (Pijnenborg et al. 2000). In mice at mid-gestation, ILCs are also
located in the mesometrial lymphoid aggregate of pregnancy (MLAp) (Sojka et al. 2019). The
MLAp surrounds the product of decidualization, the decidua basalis, which is adjacent to the
placenta. The placenta contains both maternally and fetally-derived areas and its formation
begins around gd8.5. After the placenta is fully-formed, the junctional zone is established and
separates the placental labyrinth and the maternal decidua (Coan et al. 2005, Rinkenberger et al.
2000). Each implantation site has its own MLAp, decidua basalis, and placenta.
Human implantation differs from the murine process in that a blastocyst implants into
pre-decidualized tissue. The human uterus is composed a double-layered peritoneum covering
the myometrium, which contains an interior mucous layer termed the endometrium. A similar
sequence of events occurs after implantation in human pregnancy that gives rise to an anatomical
structure comparable to the mouse. However, the MLAp in human implantation sites is
nonexistent despite the large amount of uNK cells in the myometrium (Bulmer and Lash 2005,
Trundley and Moffett 2004).
Decidualization. Decidualization refers to the process of the endometrial transformation
into the decidua (Nadra et al. 2006). Decidualization in mice is triggered by the event of

16
implantation, which can happen in various locations in the uterus at the same time, creating
multiple implantation sites (includes to the conceptus, its decidua, and the segment of overlying
myometrium). The murine estrous cycle repeats every 4-5 days and is receptive to implantation
in estrogen-high conditions in the estrus stage of the cycle. The decidua forms only after
implantation occurs. Trophoblast giant cells of the trophectoderm differentiate into primary giant
cells that regulate decidualization (Carretero et al. 2017). Throughout the process of
decidualization, vessels in the endometrium are remodeled to allow for placental perfusion and
blood flow to the developing fetus. Small, fibroblastic endometrial stromal cells (ESCs) become
large epithelioid decidual stromal cells (DSCs) during this process (Cha et al. 2012).
In humans, the endometrium is receptive to pregnancy every time the female is in the
secretory phase of her menstrual cycle, which is the phase of the cycle that contains the most
ovary-derived progesterone. The human endometrium decidualizes each month spontaneously to
anticipation of implantation. The decidua is formed under the influence of progesterone at the
end of each cycle (Pijnenborg et al. 2006). The process of decidualization is important, as it
anchors the placenta and aids in its development (Pijnenborg et al. 2006). It is formed by
fibroblast-derived stromal cells, glands, and innate immune cells, including macrophages and
group one innate lymphoid cells (ILC1s). Cytokines are important for the process of
decidualization, and certain factors, such as leukemia-inhibitory factor (LIF) are important for
mediating hormone levels that can affect the success of decidualization. Higher LIF expression is
correlated with higher fertility and supplementation of LIF in infertile women can increase
implantation (Stewart et al. 1992). Once the uterine tissue has undergone decidualization, the
placenta can form, supplying the fetus with nutrients via the maternal blood for the remainder of
the pregnancy.
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Placentation. The placenta is a fetally-derived organ that helps with nutrient and gas
exchange between fetal and maternal blood (Maltepe et al. 2010). Additionally, the placenta acts
as a barrier between the developing fetus and the maternal immune system (Bolon et al. 2015,
Blois et al. 2008). This area is called the labyrinth in mice and the villous tree in humans.
Formation of the placenta in murine pregnancy begins after implantation near gd5.5 after a
collection of immune cells, primarily NK cells, accumulates in the MLAp (Gardner et al. 1979,
Croy et al. 1993). The NK cells in this region aid in placentation through their down-regulation
of maternal immune reactions to paternally-derived EVT cells, aid in decidualization, and
mediate implantation via angiogenesis (Lima et al. 2014, Croy et al. 1993). The MLAp acts as a
placental support structure that contains maternal blood flow and extends towards the placenta.
The placental labyrinth begins to form at gd8.5, and once fully formed creates a large surface
area for nutrient and gas transport from mother to fetus (Simmons et al. 2008). The vasculature
produced through the labyrinth’s production allows for formation of other differentiated
trophoblast types (Simmons et al. 2008, Cross et al. 2003, Rinkenberger et al. 2000). The
placenta is fully formed by gd 12.5 and continues to facilitate gas and nutrient exchange to the
fetus through the remainder of pregnancy. The fetal trophoblast cells in this region are referred to
as synctiotrophoblast and express the neonatal Fc receptor FcRn that binds to maternal IgG in
low pH conditions and releases it into the villous core (Simister and Mostov 1989, Roopenian
and Akilesh 2007). This allows maternal antibodies to get into fetal circulation. MHC-I
molecules are expressed by trophoblasts, which can help determine the phenotypes of dNK cells
and their functions, especially pertaining to spiral artery remodeling (Guleria et al. 2005, Nelson
et al. 2016).
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The human placenta and embryo proper develop from the trophectoderm and inner cell
mass of the blastocyst, respectively (Silva and Serakides 2016). Cytotrophoblasts (CTB), which
differentiate from the trophectoderm, fuse with one another while the decidua rapidly
proliferates. This fusion creates a multinuclear synctiotrophoblast (STB). The STB then cause
the surrounding decidua to erode. STB incorporate maternal vessels as well as endometrial
glands to generate multiple blood-filled lacunae composed of inner CTB and outer STB layers.
Such structures are referred to as primary chorionic villi (Yabe et al. 2016). Mature STB no
longer have invasive capacity and the extraembryonic mesoderm intrudes into the primary
chorionic villi, forming the secondary chorionic villi. Tertiary chorionic villi are formed due to
differentiation of extraembryonic mesoderm into fetal blood vessels and connective tissue. CTB
and STB compose floating villi that waft into the intervillous spaces and are called villous
trophoblast cells. Where these villi anchor, CTB differentiate into extravillous trophoblast
(EVT). EVT form a cell column, which penetrates through the STB layer and reaches the
maternal decidual surface. Columns merge together and are able to encircle the implantation site,
while the EVT lose their proliferative capacity and become invasive, migrating towards the
decidua and spiral arteries (Sato 2016). It is hypothesized that this switch to an invasive capacity
is brought upon by switching of integrins on the surface of the EVT cells (Damsky et al. 1994).
PD-L1 is also expressed by trophoblasts at the maternal-fetal interface in humans, which will
inhibit T cells (Vento-Tormo et al. 2018, Brown et al. 2003, Petroff et al. 2002). Human fetal
EVTs also express HLA-G, which is a non-classical MHC class I molecule that does not exist in
mice. HLA-G has not been found to interact with the TCR on CD8 T cells but interacts with two
inhibitory receptors on myeloid cells, one of which is also present on dNK cells in humans (Apps
et al. 2008, Rajagopalan et al. 2014). The complete role of HLA-G signaling has not been
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thoroughly studied due to the lack of a mouse homolog. Trophoblast invasion occurs throughout
and following placentation.
Trophoblast invasion. Trophoblast invasion is necessary for a healthy pregnancy in
humans, as it promotes the formation of the placenta and adequate nutrient transport to the fetus.
It was discovered that high oxygen conditions promote trophoblast differentiation from
proliferative to invasive. Such cells that invade the decidua are then called interstitial
trophoblasts, and other EVT cover outlets of maternal spiral arteries form trophoblast plugs.
These plugs occlude spiral arteries and disrupts blood flow to the intervillous spaces and reduce
the partial pressure oxygen in the intervillous space to a pressure far below that of the decidua or
the arteries (Burton et al. 1999). It is hypothesized that the pressure of the arteries compared to
the decidual space is why trophoblast cells invade arteries rather than veins, and why the
instances of preeclampsia are heightened in areas of high altitude (Julian 2011). The trophoblast
plugs slowly dissociate and the cells migrate along the arterial wall that allows communication
between spiral artery and intervillous space to occur. Such EVT cells that move upstream are
known as endovascular trophoblasts, which will continue blood flow into the intervillous space,
increasing the partial pressure of oxygen in the intervillous space (Jauniaux et al. 2001).
EVT ensure placental blood perfusion, and endovascular trophoblast replace the
endothelium and destroy the arterial muscular lining. It is hypothesized that the replacement is
enabled by expression of vascular endothelial cadherin and integrins on the endovascular
trophoblasts (Zhou et al. 1997a,b). This allows the spiral artery to transform into large-caliber
vessels to increase arterial blood flow into the intervillous spaces and contributes to successful
pregnancy. The chemokine receptor CCR1, which binds CCL5, and CD59 are expressed on
endovascular trophoblasts but not on interstitial trophoblasts. CCR1 would act to promote
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endovascular trophoblast invasion (Sato et al. 2003), while CD59 was found to dampen
complement attack by maternal cells against the trophoblast cells (Ueda et al. 2019).
Trophoblast invasion in murine pregnancy is restricted to mesometrial decidua and is
mostly interstitial (Ain et al, 2003). uNK have been shown to secrete TGF-Beta which reduces
EVT migration (Lash et al. 2010). Recently, it was discovered that NK cell-derived Gab3 is
important for the limitation of trophoblast invasion, as a knockout caused excessive EVT
invasion in mice (Sliz et al. 2019). Invasion of EVTs into the decidua must be regulated, since
suboptimal invasion or excess invasion of these cells can lead to pregnancy complications such
as fetal growth restriction, pre-eclampsia, placenta accrete, and spontaneous miscarriage
(Brosens et al. 2011).
Cells in pregnancy. Mouse decidual stromal cells (DSCs) have reduced transcripts of
Cxcl9, Cxcl10, Cxcl12, and Cxcl16, decreasing their ability to recruit other immune cells known
to attack fetally-derived cells, such as type-1 polarized T cells. This category includes both Th1
cells and cytotoxic T-lymphocytes (CTLs). Mouse DSCs also have decreased Csf1,
downregulating its ability to promote growth of macrophages (Nancy et al. 2012, 2018). DSCs
establish this transcriptional state through endocrine signaling with little-to-no input from the
fetus. The transcriptional profile and mechanism of DSCs in mice is not fully understood, and it
has been found to change throughout pregnancy for the needs of the fetus and the health of the
pregnancy. For example, endometrial stromal cells (ESCs), which become DSCs in pregnancy,
respond to progesterone treatment via upregulation of IL-15 and CXCL14, changing the uterine
environment and promoting NK cell recruitment and proliferation (Katoh et al. 2018).
The uterus also contains other types of innate lymphoid cells. ILC2s are also
hypothesized to promote fetal growth in pregnant mice. ILC3s and LTi cells both express RORγt
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and have been found to help development of lymph nodes in human fetuses, but they are also
found in murine uteri (Cella et al. 2009, Male et al. 2010, Doisne et al. 2015, Montalado et al.
2016). Rorγt+NKp44+ cells dominate the endometrium while in the decidua. NCR+ ILC3s
produce IL-22 and NCR- ILC3s (LTis) produce TNF when activated (Vacca et al. 2015).
However, the most abundant cells at the implantation site are the DX5-CD49a+ trNK cells
(Doisne et al. 2015, Boulenouar et al. 2016, Sojka et al. 2014), which were found to be resident
in both the pregnant and virgin murine uterus through parabiosis studies (Sojka et al. 2014,
2018). Based on their expression of CD49a and eomesodermin (Eomes), uNK cells can be
divided into three subsets: conventional NK (cNK), tissue resident NK (trNK) and ILC1s
(Filipovic et al. 2018, Sojka et al. 2014, 2018). It was originally thought that cNK influx at day
8.5 of pregnancy and then aid in spiral artery remodeling through their production of IFN-γ.
NFIL3 deficient mice lack cNK cells but still have ILC1s and trNK cells. They also exhibit
suboptimal spiral artery remodeling. Loss of NK cells in mouse models is associated with
abnormalities in the decidua, suboptimal vascular remodeling, and fetal growth restriction (Fu et
al. 2017, Boulenouar et al. 2016).
Acquiring human pregnancy tissues poses ethical issues. Most human studies have been
accomplished through voluntary tissue samples after elective early-pregnancy abortions.
Maternal platelets have been found scattered among endovascular trophoblasts in human studies
(Sato et al, 2005). It is suggested that this occurs due to the collagen and fibronectin matrices
released by trophoblasts. In vitro co-culture with EVT cells and platelets enhances invasion of
such EVT cells and caused them to differentiate towards the endovascular trophoblast
morphology, while EVT cells cultured without platelets led to a morphology resembling
interstitial trophoblast, indicating that the activated platelets in the placental bed in human
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pregnancy release soluble factors that are important for the differentiation of trophoblast cells,
and therefore are ideal spiral artery remodeling (Sato et al. 2010).
Human uNK were initially described as CD3-CD56+ lymphocytes. A recent study
isolated cells from the elective first-term abortion samples and performed single-cell RNA
sequence analysis. The study revealed the extensive heterogeneity among the uterine NK cells
and identified 3 clusters of NK cells in human pregnancy (Vento-Tormo et al. 2018,
Suryawanshi et al. 2018). In the decidua, there are three distinguishable NK populations, a
proliferating NK cell subset, and ILC3s. One such subset most closely resembled intra-epithelial
ILC1s, while none of the populations showed ILC2s or classical ILC1s. This study also showed
vast heterogeneity amongst decidual stromal, epithelial, and various other immune cells.
Endometrial RNAseq showed heterogeneity as well. Human dNK cells diverge in CyTOF
analysis based on differential KIR expression (Huhn et al. 2020), indicating that the protein
expression of KIR receptors may correlate to populations of ILCs in the pregnant uterus that
have different functions. Some subsets contained more responsiveness to missing self or to
stimulation than others, but their interactions with trophoblast cells has not yet been studied.
NK cells are mainly classified in humans as either CD56dimCD16+ or CD56brightCD16cells, the latter of which are found more often in the endometrium, and the former are found
more often throughout the peripheral blood (Gaynor et al. 2017). CD56brightCD16- cells make up
20% of leukocytes in the proliferative phase, 45% in the secretory phase, and about 70-80% in
the decidua during early pregnancy (Liu et al, 2017). It was discovered that this proliferation is
due to the progesterone-induced secretion of IL-15 by stromal cells in the uterine
microenvironment in pregnancy (Wilkens et al. 2013). Although endometrial NK (eNK) cells
contain tissue residency markers, they are cytotoxic, unlike mouse tissue resident NK cells
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(Manaster et al. 2008, Eriksson et al. 2004, Jones et al. 1998). Various hypotheses exist
regarding the role of these NK cells, as they are inconsistently present amongst the locations
within implantation site, and no correlation has been found between levels of these cells and
pregnancy outcomes (Tang et al. 2011, Seshadri et al. 2014). dNK cells are most commonly
found near migrating interstitial trophoblasts (Helige et al, 2014) and spiral arteries (Smith et al,
2009), indicating that these cells are involved in human spiral artery remodeling by disruption of
the muscular lining and interacting with the trophoblast that carry out the remodeling.
The first trimester and its decidual NK cells (dNK) have been studied much more than
endometrial NK cells in nonpregnancy. KIR expression on eNK differs compared to pbNK and
dNK (Male et al. 2011, Ivarsson et al. 2017). dNK cells in human pregnancy also contain tissue
residence markers and KIR receptors (Male et al. 2011, Koopman et al. 2003, Sharkey et al.
2008, Marlin et al. 2012, Xiong et al. 2013). However, unlike eNK cells, their transcripts of
natural cytotoxicity receptors are decreased (Kopcow et al. 2010). Thus, these cells exhibit less
cytotoxicity towards non-self cells, such as paternally-derived EVTs (Siewiera et al. 2015).
When stimulated in vitro, activated dNK cells can produce factors such as IL-8, IIP-10, and GMCSF (Hanna et al, 2006; Xiong et al, 2013), all of which can influence movement of
endovascular trophoblasts. Decidual NK cells drastically decrease in number in the latter half of
pregnancy; they downregulate their KIR expression and show reduced cytotoxicity (de
Mendonca Vieira et al. 2020).
At human implantation sites in the first trimester, when spiral artery remodeling occurs,
almost all of the cells are CD49a+ dNK1 and dNK2, which are CD49ahiEOMEShiTBX21lo and
CD49aintEOMESintTBX2int, respectively (Vento-Tormo et al. 2018, Montaldo et al. 2015, Huhn
et al. 2020). dNK3 cells are similar to intraepithelial ILC1s (Vento-Tormo et al. 2018, Huhn et
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al. 2020). dNK1s seem to expand and exhibit a “memory” profile, becoming more abundant and
effective in subsequent pregnancies (Gamliel et al. 2018). However, such cells do not have a
high capacity to produce cytokines upon stimulation (Huhn et al. 2020). dNK cells respond to
TGF-beta and IL-15 through increased activating and inhibitory receptor expression (Montaldo
et al. 2015, Huhn et al. 2020, Siewiera et al. 2015, Keskin et al. 2007, Cerdeira et al. 2013, El
Costa et al. 2008). NK cells undergo education processes in the endometrium prior to pregnancy
and in the decidua throughout pregnancy. This process influences the expression profile of
activating and inhibitory receptors expressed on NK cells in that tissue (Menaster et al. 2008,
Male et al. 2011, Yadi et al. 2008). Additionally, dNK1 cells express LILRB1, which interacts
with HLA-G on EVT cells directly (Vento-Tormo et al. 2018, Huhn et al. 2020). After such
interactions, dNK1s may change their expression profile even further and change their secretion
patterns, including reduced cytotoxicity toward MHC-I deficient cells (Fu et al. 2017, El Costa et
al. 2008, Xiong et al. 2013).
ILCs in the human decidua are different from most other organs that they have been
studied in, including other mucosal surfaces (Simoni et al. 2017, Huhn et al. 2020). Such
differences indicate that the developmental pathways leading to NK and other ILCs vary from
organ-to-organ (Guia et al. 2020). The first trimester decidua contains more ILC1s than the lung
and less ILC3s than the colon and tonsils. dNKs are also different from trNK in other sites in that
they express high amounts of KIR and NKG2A (Yudanin et al. 2019). Incredible diversity of
ILC subsets arises within the decidua, as well as diversity amongst individuals as described by
mass cytometry and CyTOF. KIR expressing cells occur most frequently in the tissue-resident
decidual NK cells. It is still unclear how the phenotypic diversity of populations within and
between women influences pregnancy outcomes.
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In humans, some pbNK cells have displayed memory-like properties with an expansion
of some subsets after CMV infection (Beziat et al. 2013). It was also hypothesized that liver
resident NK cells mediate contact hypersensitivity and could represent memory NK cells (Peng
et al. 2013). Such expansion is also seen in secondary and subsequent pregnancies, which are
termed pregnancy-trained decidual NK (PTdNK). Transcriptomic profiles of these cells indicate
that they are producers of IFN-γ and VEGF-A, which may help aid in ideal trophoblast invasion
or arterial remodeling in secondary pregnancies (Gamliel et al. 2018). The role of dNK1 in
pregnancy is unclear, as they usually do not produce IFN-γ or VEGF-A when isolated unless
they are activated with IL-15 (Siewiera et al. 2013, Vacca et al. 2008). Memory cells could be
essential for efficient spiral artery remodeling or limiting EVT invasion. First pregnancies in
humans tend to have higher risk of low birth weight or pre-eclampsia, both of which are results
of suboptimal spiral artery remodeling and further supports this hypothesis (Kozuki et al. 2013,
Hernandez-Diaz et al. 2009, Prefumo et al. 2006). Murine uILC1s may be the functional
counterparts to human PTdNK memory cells but exhibit low Ly49 expression (Gamliel et al.
2018).
Spiral artery remodeling. The prominent roles of dNK cells in humans and trNK cells
in mice are to provide developmental support through cytokines, chemokines, and growth
factors, as well as aiding in the process of spiral artery remodeling. Spiral artery remodeling
ensures adequate perfusion of the placenta with maternal blood to allow for nutrient and gas
exchange with the fetus (Moffett and Colucci 2014, Sojka et al. 2019, Gaynor and Colucci
2017). During pregnancy, the uterine spiral arteries are altered to become high conductance
vessels (Burton et al. 2009). This allows for greater blood flow, and thus, nutrient flow, to the
fetus.
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In mice, trophoblast invasion is not necessary for ideal spiral artery remodeling. Instead,
it is understood that spiral artery remodeling is carried out by NK cells that move into the arterial
wall (Gaynor et al. 2017, Ain et al. 2003, Kieckbusch et al. 2014). Croy et al. found that mice
deficient in NK cells rather than those deficient in trophoblast cells have defects in spiral artery
remodeling (Croy et al, 2000). Murine uNK have been found to secrete IFNγ and VEGF-C, both
of which are important for the process of spiral artery remodeling. Mice without the VEGF-C
receptor (VEGFR3) on endothelial cells shows reduced vessel remodeling and fetal growth
restriction, proving that NK cell secreted factors interact directly with the endothelial artery
lining and surrounding smooth muscle (Pawlak et al. 2019).
IFNγ is important for arterial remodeling, as mice that lack IFNγ or its receptor have
defects in this process and lower fetal weights. Bone marrow chimera from IFN-γ deficient mice
into Rag2-/-γc-/- mice does not reverse the phenotype of negligible spiral artery remodeling,
while IFN-γRα deficient bone marrow, which contains IFNγ, rescues the phenotype. These
results indicate the importance of IFNγ signaling through the IFN-γRα receptor is essential for
this process (Ashkar et al. 2000). Administration of IFNγ rescues decreased spiral artery
remodeling in tge26 mice (which lack NK and T cells), as well as bone marrow grafts from
SCID mice that possess only NK cells but not B or T cells, indicating that IFNγ from NK cells
specifically is required for spiral artery remodeling (Ashkar et al. 2000, Guimond et al. 1998,
Barber et al. 2003). Mice lacking NKG2A, NCR1, or AhR show defective NK cell maturation,
abnormal spiral artery remodeling, and lower fetal weights. (Felker et al. 2013, Shreeve et al.
2021). NFIL3 knockout mice, which lack cNK but not trNK or ILC1s, have a phenotype of fetal
growth restriction, indicating that NK and ILC subsets in the pregnant murine uterus produce
more factors than just IFNγ that promote placental development (Fu et al. 2017). In the absence
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of dNK cells in the mouse, such as Rag2-/-, Il2rg-/- and Il15-/- mice, vessels retain smooth
muscle cells, have thick walls with narrow lumens, and do not undergo hemodynamic
adaptations (Ashkar et al. 2000, 2003, Barber et al. 2003, Zhang et al. 2011). These results
combined indicate the importance of NK cell presence and secretion of IFNγ at the maternalfetal interface for spiral artery remodeling. However, the role of Ly49 receptors in these NK cell
functions in pregnancy have yet to be studied.
Fetal trophoblast cells invade as far as the inner myometrium in human pregnancies. In
remodeling vessels, the trophoblast cells can mediate fibrinoid necrosis of arterial media that
transforms the vessels (Pijnenborg et al. 2006, Ander et al. 2019). In humans, fetal trophoblasts
invade both intravascularly and through the decidua and extend into the inner myometrium
(Pijnenborg et al. 2006, Ander et al. 2019). EVT cells help with the process of arterial
remodeling through interactions with maternal cells at the maternal-fetal interface (Fu et al.
2017, Cartwright et al. 2010). It is assumed that interaction between interstitial trophoblast cells
and maternal dNK cells is necessary to activate dNK cells and allow trophoblast invasion to
complete full spiral artery remodeling.
During the late secretory phase of the human menstrual cycle, a process of trophoblastindependent spiral artery remodeling occurs. This process is characterized by partial loss of
arterial muscular lining and endothelial swelling and is thought to be primarily mediated by dNK
cells and macrophages (Pijnenborg et al. 2006, Smith et al. 2009, Lash et al. 2016). Once
trophoblasts arrive to the area, trophoblast-dependent remodeling occurs in two stages (Sato et
al. 2012). The first phase involves perivascular interstitial trophoblasts further disrupting the
muscular lining of the arteries and embed into the fibrinoid material (Shih et al. 2006), followed
by a stage in which endovascular trophoblasts travel up the arterial wall, where they disrupt the
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endothelium and muscular lining of the arterial lumen. Perivascular interstitial trophoblasts pave
the way for subsequent endovascular trophoblast invasion (Pijnenborg et al. 1983). The
morphologies are different between endovascular trophoblasts and the CTB cells in the basal
layer of the cell column, indicating that different types of trophoblast cells undergo distinct
differentiation pathways (Pijnenborg et al. 2006, Shih et al. 2006). In vitro analysis has enabled
characterization of cytokines and soluble factors that can either promote invasion or restrain it.
IFNy production by dNK cells has not been found to be as important for arterial
remodeling in human pregnancy as it is in murine pregnancy (Croy et al. 2006). However, when
dNK are activated in vitro to secrete IFNy, IDO production by decidual CD14+ as cells occurs, as
well as expansion of regulatory T cells (Erlebacher et al. 2013). Decidual NK cells that are
clustered around spiral arteries in human pregnancies express angiogenic factors, including
VEGF-C and PLGF, both of which can regulate endothelial cell function (Li et al. 2001). In
terms of spiral artery remodeling, dNK cells produce MMP-9, which breaks down the
extracellular matrix of the vascular smooth muscle wall. Decidual NK cells also produce VEGFC and angiopoietins-1 and -2 (Hanna et al. 2006, Li et al. 2001, Lash et al. 2006, Hazan et al.
2010). Asoprisnil, a progesterone modulator, results in absence of eNK and altered arterial
morphology but did not cause menstrual bleeding. It does this by blocking IL-15 secretion by
stromal cells as a response to progesterone, emphasizing the importance of IL-15 for spiral artery
remodeling in human pregnancies (Robson et al. 2012, Wilkens et al. 2013).
Spiral artery remodeling is one of the most important processes in pregnancy, as fetal
growth is restricted if nutrient supply is insufficient. Understanding the signaling pathways and
cells that are involved in the process has important implications for potential preeclampsia
prevention or treatment. Natural Killer cells and EVT have proven important for the process, but
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the role of Ly49 receptors and the missing-self hypothesis in spiral artery remodeling success has
not been addressed.

NK Cells and Pregnancy Complications
There are many suboptimal symptoms that can arise in human pregnancy, many
of which are due to a grouping of syndromes termed “The Great Obstetrical Syndromes.” These
syndromes are characterized by their numerous etiologies, extensive preclinical periods, their
adaptive natures, and involvement of the fetus. These syndromes overall describe the complex
relationship and interactions between the fetal and maternal genomes (1-4). Many common
observations in human pregnancy, including preeclampsia, small or large for gestational age,
preterm rupture of membranes, preterm labor, and stillbirth, are categorized as great obstetrical
syndromes that have multiple causes (Romero 2009). Obstetrical syndromes are mostly caused
by defects in placentation and inadequate spiral artery remodeling (Brosens et al. 2010).
Defective deep placentation is described as having a significant increase in the number of absent
or partial transformed spiral arteries. Such restricted blood flow can also give rise to obstructive
arterial lesions that contribute to suboptimal placentation (Brosens et al. 2010). Disordered
placentation can give rise to a variety of clinical complications that affect the health of the
pregnancy overall. It has been hypothesized that cyclic menstruation in women allows for a
preconditioning to occur in which the uterine tissue is conditioned to withstand the inflammation
caused by pregnancy. Elastic lamina of the spiral arteries in the myometrium remains intact after
first pregnancy, which could explain higher birth weights in subsequent pregnancies (Khong et
al. 2003).
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Insufficient spiral artery remodeling is one of the leading causes of preeclampsia
(Huppertz 2008), and less than 5% of preeclamptic women have fully remodeled spiral arteries at
the time of delivery (Kim et al. 2002). This disease state is characterized by maternal
hypertension and proteinuria. Insufficient spiral artery remodeling in the junctional zone portion
of the maternal-fetal interface is the first stage, causing fetal growth restriction due to lack of
blood flow into the intervillous spaces (Redman and Sargent 2005). Anti-angiogenic factors then
cause systemic hypermutation and proteinuria are released from the villi into maternal circulation
(Rana et al. 2019). Placental ischemia will occur, which induces an immune imbalance involving
increased production of pro-inflammatory immune cells and cytokines and decreased regulatory
cells and cytokines. A state of chronic inflammation ensues (Harmon et al. 2016). The
mechanism in which spiral artery remodeling contributes to the pathogenesis of preeclampsia is
not yet clear, but the defective arterial transformation is more prevalent in the myometrium of
preeclamptic patients than in the decidua (Kim et al. 2003, Guzin et al. 2005). Preeclampsia can
also be accompanied by intrauterine fetal growth restriction. Preeclamptic patients with growth
restricted fetuses have large numbers of nontransformed spiral arteries in the myometrium that
often contain lesions (Robertson et al. 1967, Brosens et al. 1977). Fetal weights can be caused by
a multitude of situations, but low fetal weights tend to be accompanied by other obstetrical
syndromes. Spiral artery remodeling defects were seen primarily in the decidua in such cases
(Khong et al. 1986).
Defective spiral artery remodeling has also been associated with a multitude of other
obstetrical syndromes that can be fatal to both the fetus and the mother. These syndromes include
late spontaneous abortion and preterm labor, both with membranes intact and rupture of the
membranes (Khong et al. 1986, Ball et al. 2006, Kim et al. 2002,2003). Women with infections,
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vascular or cervical diseases, allergy, and endocrine disorders are at higher risks for these
complications (Romero et al. 2006) Preterm rupture of membranes (PROM) is highly correlated
with nontransformed spiral artery. Additionally, the spiral arteries of women in preterm labor are
significantly reduced in remodeling compared to women who give birth at term (Kim et al.
2003). Women undergoing late spontaneous abortion similarly have high numbers of failed
spiral artery transformation (Khong et al. 1987). Reduced endovascular and intramural
trophoblast cells were seen in these arteries, which could be the cause of reduced spiral artery
remodeling in such patients (Ball et al. 2006).
Due to NK cells’ functions at the maternal-fetal interface and their role in spiral artery
remodeling, biomarkers on such cells could be indicative of risk factor for obstetrical syndromes.
Current predictive and preventative measures for the great obstetrical syndromes involve
analysis of the mother’s symptoms and the physical structure of her womb. However,
understanding of processes specific to pregnancy could lead to more efficient preventative
practices. The overall study of Natural Killer cells and their abilities to affect pregnancy
outcomes may offer a new method for predicting obstetrical syndromes. Ly49 receptors are not
present on human NK cells, but they are the functional equivalent to KIR receptors on human
cells. Through study of the role of Ly49/MHC-I interactions in murine pregnancy, we can better
understand what roles KIR receptors may play in human pregnancy. This would allow physicians
to predict any possible complications before a pregnancy begins, bettering preventative
obstetrical care in the future.

CHAPTER THREE
MATERIALS AND METHODS
Mouse Models
WT C57BL/6J mice were purchased from Jackson Laboratories, and Ly49KO and
D8KODO mice (kindly provided from the Yokoyama Lab), eomes-gfp mice (kindly provided
from the Waltzer Lab), and NFIL3KO (kindly provided from the Rothman Lab) were maintained
in house. All strains were on a B6 background. Sexually mature females ages 6-12 were used for
experiments involving virgin mice, and pregnant mice at gestational day 9.5 were all between the
ages of 6 and 16 weeks old. Mice were age-matched for all experiments and time matings.
Gestational day 0.5 refers to the sight of a copulation plug in the morning. Mice were bred,
maintained, and mated under pathogen-free conditions at Loyola University Chicago in
Maywood, IL.
Organ and Cell Isolation
Mouse uterus, implantation sites, and maternal pregnancy tissues were processed using
both mechanical and enzymatic processing. Minced tissues were digested with Liberase (34
ug/mL) and DNAse (100ug/mL) for 20 minutes at 37°C. Following digestion, tissues were
passed through a 100 um cell strainer using a plunger. Cells were suspended in HBSS with 2%
FBS as a single cell suspension. Spleens were passed through a 70 um cell strainer using a
plunger and red blood cell lysis was performed for 3 minutes on the resulting cell pellet using
RBC lysis buffer. Single cell suspensions of spleens and uterine tissues were used for

32

33
downstream analysis and culture. Cells were suspended in HBSS with 2% FBS as a single cell
suspension.
Sample Preparation for Confocal Microscopy
WT and Ly49KO mice were injected with α-CD31 to intravascularly label endothelial
cells in blood vessels and were sacrificed 30 minutes post-injection. Gestational day 9.5
implantation sites or virgin uterus were fixed in 4% PFA (Thermo scientific- J19943-K2) for 90
minutes, followed by three 15 minute washes in 1x PBS. Tissues were then placed in 2% PBST
overnight to allow for permeabilization, followed by a second round of washes in 1x PBS. For ex
vivo staining for smooth muscle actin, tissue was placed in blocking buffer (1x PBS with 10%
FCS and 1% TWEEN) for 4 hours, followed by one hour in Fc block and overnight in a 1:100
stain in 1x PBS. Excess stain was washed off of the tissue with three, one hour washes in 1x
PBS. Each step was completed in light-blocking tubes on a rocker at room temperature. Tissues
were mounted in RapiClear 1.52 (Sunjin Lab- #RC152001) media on a glass slide with Sunjin
Labs 0.25mm spacers (Sunjin Lab- #IS213) to allow for whole mount. Samples were imaged on
a Zeiss LSM 510 confocal microscope at 25x magnification and 0.7 optical zoom. Maximum
intensity projections were analyzed using Imaris 9.7.2 image analysis software using the filament
tracer tool to measure the diameter, volume, area, and straightness of vessels.
Mouse Injections
Intravascular labeling of uterine blood vessels was done via tail vein injection. Mice were
injected with 3ug APC-conjugated anti-CD31 in 50ul. Mice were sacrificed 30 minutes later, in
which the uterus and implantation sites were removed and processed for confocal imaging.
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Injections of brefeldin A (BFA) (Sigma-B6542-5MG) was done via intravascular tail
vein injection. 500 ul of a 0.5mg/mL freshly made in room-temperature PBS and injected via the
murine tail vein 3 hours pre-sacrifice based on the protocol published in Foster et al. (2007).
Hormone injections for synchronization were done via intraperitoneal injection for 2 or 3
days in a row. Beta-estradiol 17-valerate (E2: Sigma- BCBL-95U7V) or P8783-1G (P4: SLBS7040) suspensions were 100ul of 10mg/mL dissolved in 10% acetone and diluted in sesame oil.
All injections were done using a 27G needle.
Cell Culture and NK Cell Stimulations
For plate-bound anti-NK1.1 stimulation, unconjugated leaf-grade anti NK1.1
(BioLegend) was plated in 48 well flat-bottom plates at 5ug/mL and placed in incubator for 1
hour and washed 3 times with PBS before adding 1 x 106 cells per well. IL-15 was added at
100ng/mL in 10% FBS RPMI complete media supplemented with 2Me, L-glutamine , penicillin,
and streptavadin. After 1 hour at 37°C, brefeldin A (BFA) was added to the culture at 1:1000
dilution and the culture was allowed to be incubated for 5 more hours. Cells were harvested
using a pipette tip to disturb the cell layer and stained using the flow cytometry protocol.
For hormone stimulation, eomes gfp mice were sacrificed and spleens and uteri combined
into single cell suspensions. Spleen suspension was enriched for NK cells. Enrichment was done
using biotinylated aCD3 and aCD19 at 1:100 dilution added directly to sample for 20 minutes
and conjugated cells were removed via Miltenyi magnet and all cells were suspended in sort
buffer (10% FCS in 1x PBS). Cells were surface stained using flow cytometry staining protocol
(below) before fixation and sorted based on eomes and CD49a expression (eomes+CD49a- cNK,
eomes+CD49a+ trNK, and eomes-CD49a+ ILC1). Recovered cells were then cultured in 10%
charcoal: dextran stripped FBS (Gemini bio) in RMPI complete media supplemented with 2Me,
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L-Glutamine, penicillin, and streptavidin. Cells were plated at 10,000 cells/well in a 96 well U
bottom plate with 2ng/mL IL-15 for 3 days with a media change every 24 hours. After culture,
cells were restimulated with estrogen (Sigma- E2758-1G), progesterone (Sigma-P8783-1G), or
both, kept in 2ng/mL IL-15, or in charcoal:dextran stripped fetal bovine serum alone for 6 hours
with BFA at 1:1000 dilution. Cells were harvested and stained for flow cytometry analysis
(below).
Flow Cytometry
In vitro cultured cells or ex vivo single cell suspensions were stained in falcon tubes.
Live-dead stain for 30 minutes, followed by a wash in 2% FCS in 1x PBS buffer and centrifuged
at 1250 rpm for 5 minutes at 4°C. An antibody cocktail of cell-surface marker antibodies was
constructed at dilutions according to company instructions and applied to cells for 1 hour
following 10 minutes in 2.4G2 Fc block. Another wash in buffer was performed. Cells were
fixed with True-Nuclear™ Transcription Factor Buffer Set according to instructions and stained
intracellularly overnight with intracellular antibodies in 1x permeabilization buffer. Antibodies
were diluted according to manufacturer’s instructions. Cells were filtered through 70um nylon
mesh cell strainer to remove debris, and samples were run on a BD-LSRFortessa and analyzed
using FlowJo analysis software.
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Antibodies
Target

Company

Clone

Catalog

Dilution

CD3
CD3
CD11b
CD19
CD19
CD27
CD27

Biolegend
Biolegend
Biolegend
Biolegend
Thermo-Fisher
Biolegend
Biolegend

145-2C11
145-2C11
M1/70
6D5
eBio 1D3
LG.310A
LG.310A

100320
100362
101243
115520
47-0193-82
124238
124238

1:100
1:100
1:100
1:100
1:100
1:50
1:100

CD31
CD45
CD49a
CD49a
Eomesodermin
Eomesodermin
Fc Block
Fc Block
Granzyme B
Granzyme B
IFN Gamma
Ly49A
Ly49A B6
Ly49D
Ly49D
NK1.1
NK1.1
Smooth Muscle
Actin

Biolegend
Biolegend
BioDot
BioDot
Thermo-Fisher
Thermo-Fisher
Biolegend
Biolegend
eBioscience
Biolegend
Biolegend
Biolegend
Biolegend
eBioscience
Biolegend
eBioscience
Biolegend

390
30-F11
Ha31/8
Ha31/8
Dan11mag
Dan11mag
S17011E
93
NGZB
GB11
XMG1.2
YE1/48.10.6
A1/Ly49A
4.00E+05
4.00E+05
PK136
PK136

102410
103128
562115
740046
50-4875-82
46-4875-82
156604
101320
50-8898-82
515408
505813
116808
138703
17-5782-82
138303
45-5941-82
108748

1:100 (FACS)
none (IV labeling)
1:100
1:100
1:100
1:500
1:500
1:1000
1:500
1:500
1:500
1:500
1:100
1:100
1:100
1:100
1:100
1:100

eBioscience

1A4

41-9760-82

1:100

CHAPTER FOUR
PHENOTYPE OF LY49KO PREGNANCIES
Fetal weights of Ly49KO mice are significantly reduced. Ly49KO mice are
completely devoid of Ly49 receptors on their NK cells (Parikh et al. 2020). As a new knockout,
not much is known about the effect of such a knockout on basic NK functions, including in
pregnancy. Since NK cells are known to participate in limiting trophoblast invasion and spiral
artery remodeling, we wanted to know whether loss of Ly49 receptors on such NK cells affected
pregnancy outcome.
Fetal weights are often used as pregnancy success in mice, as there is no comparison for
preeclampsia. Fetuses from both WT and Ly49 pregnancies were analyzed with mating partners
of both WT and D8KODO. D8KODO males have transgenic expression of H2-Dd and a
knockout of H2-Kb and H2-Db, causing maternal NK cells to be exposed to only paternally
derived H2-Dd. Compared to WT females mated with WT sire, pregnant females with D8KODO
males had significantly reduced weights, indicating that fetal/paternal MHC genotype affects
fetal growth. A similar finding was noted in WT female/D8 male mating pairs (Kieckbusch et al.
2014). Similarly, Ly49KO females mated with WT males had litters that had significantly
reduced fetal weights. This similar phenotype indicates that not only is fetal MHC important for
spiral artery remodeling, but the interaction of fetal MHC with maternal Ly49 receptors as a
whole impacts processes that affect fetal weights.
This concept is further supported in that the most severe fetal weights came from
Ly49KO/D8KODO mating pairs (Figure 1a). Ly49KO females overall gave birth to a
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significantly higher number of pups that fell in the fifth percentile of birth weights, especially
when mated with D8KODO males, compared to WT females regardless of mating partner
(Figure 1b). This finding maintains that Ly49 receptor interactions with MHC class I molecules
on fetally-derived trophoblasts is important for maintaining a healthy pregnancy in mice. We
hypothesize that this interaction is important for the NK cell-mediated process of spiral artery
remodeling through their production of IFNγ.

Figure 1. Fetal Growth Restriction in Dams that Lack Ly49 Receptors. WT B6 and
Ly49KO females were time-mated with WT B6 or D8KODO males, with a copulation plug
indicating gd0.5. At gd18.5, the weights of pups were measured for each mating pair. (A)
Weights of pups from each mating pair on gd18.5. (B) percentage of pups from each mating pair
that fell below the 5th percentile of B6 x B6 pup weights. White bars indicate B6 female pups and
grey bars indicate pups from Ly49KO females. The number of pups analyzed is indicated above
the corresponding bar. *p<0.05 **p<0.01 ***p<0.001 ****p<0.0001.
Ly49KO NK cells mature normally. NK cells that express NK1.1 have various stages
of maturation, commonly delineated by CD27 and CD11b. Cells begin by expression of CD27
followed by dual expression with CD11b, and the most mature cells lose CD27 and are
CD11b+CD27-. Ly49KO cells have not been studied for their ability to properly mature.
Phenotyping NK cell maturity in the spleen, uterus, and at implantation sites is necessary for
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ensuring that any further phenotype in pregnancy is due to the lack of Ly49 receptors,
specifically, rather than lack of maturity due to a deficiency in Ly49 receptors. It is unknown
whether Ly49 receptors are required for uNK cells’ maturation in the uterine tissue environment.
Figure 2. Ly49 Receptors are not Required for the Maturation of NK Cells in the Uterus

and Pregnancy-Derived Uterine Tissues. NK cells were isolated from the virgin uterus, and the
MLAp and decidua's from pregnant WT B6 or Ly49 knockout females. Percentages of
CD45+CD3-CD19-NK1.1+ cells expressing the maturation markers CD27 and CD11b were
analyzed via flow cytometry. (A) total NK cell population, (B) eomes+CD49a- conventional NK
cells, (C) eomes+CD49a+ tissue resident NK cells, and (D) eomes-CD49a+ ILC1s. n= 6 virgin
WT B6 and 7 virgin Ly49KO, 5 pregnant WT B6 and 4 pregnant Ly49KO females, each with 4
MLAp and decidua analyzed.
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NK cells from the virgin uterus, MLAp, and decidua from WT and Ly49KO mice were
analyzed for their expression of CD27 and CD11b. NK1.1+ cells overall tend to become less
mature in pregnancy tissues, with CD27+CD11b- cells predominating in the MLAp and decidua,
whereas both WT and Ly49KO virgin uterine tissue had higher amounts of fully mature NK cells
(Figure 2a). Conventional NK cells in all tissues regardless of genotype maintained high levels
of maturity, while tissue-resident NK cells and ILC1s were predominated by CD27+CD11b- and
CD27-CD11b- fully immature cells, respectively (Figure 2b, 2c, & 2d). Tissue resident NK cells
moved from fully immature double negative cells in virgin tissue from both strains to a more
mature CD27+CD11b- phenotype in pregnancy tissues, which was not affected by the Ly49
knockout (Figure 2c). The maturation profile of cNK or ILC1 did not change during pregnancy
(Figure 2d). Tissue resident NK cells may represent activated NK cells, and further activation in
pregnancy may cause them to mature further. However, the maturation markers classically used
to describe cNK cells have not been characterized or described in other NK cell subsets,
including ILC1s. Such markers may not be an accurate description of the maturity levels of cells
in the uterine tissue. Since Ly49KO NK cell maturation was not affected by the lack of Ly49
receptors, it can be assumed that any functional changes in pregnancy of these mice is due to the
loss of Ly49 receptors.
Ly49D and Ly49A are expressed by uterine NK cells. The role of Ly49 receptors has
not been analyzed in the various NK cell subsets in the uterus in pregnancy. We phenotyped the
expression of Ly49D, an activating receptor, and Ly49A, and inhibitory receptor. Both Ly49D
and Ly49A interact with the MHC-I haplotype H2-Dd, an allogeneic haplotype to C57Bl/6J
mice, but intrinsic to BALB/c mice and expressed in D8KODO mice. WT mice were analyzed
for their expression of these Ly49 receptors on the NK cells isolated from the spleen, uterus, and
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implantation site. Conventional NK cells do not change their expression, with the majority of
cells containing Ly49A with some dual expression of Ly49D (Figure 3, Table 1). We found
trNK cells routinely have an increased frequency of Ly49D single positive cells in the uterus, the
MLAp, and the decidua in pregnancy with minimal amounts of Ly49A single positive or double
negative cells (Table 1). ILC1s have slightly more Ly49A+Ly49D- cells in the control uterus than
the trNK, but the majority of the cells are still Ly49D+Ly49A-, with a higher percentage of
double negative cells than trNK cells as well. Additionally, ILC1s have similar Ly49A and
Ly49D expression in the MLAp and control uterus conditions but shift towards a conventional
NK cell profile in the decidua. There are high amounts of double negative ILC1s in the decidua
accompanied by a high percentage of Ly49A+Ly49D- cells. Unlike cNK cells, however, they do
not have high levels of double positive cells (Figure 3, Table 1).
Since the origin of ILC1s in the uterus and implantation sites is still unknown, we
hypothesize that ILC1s in the uterus, especially in the decidua, may be cNK cells that
downregulate Eomes during pregnancy. In the conditions of constant stimulation, it has been
shown that cNK cells begin to downregulate their eomes expression, and in IL-15, cNK cells
begin to upregulate CD49a. The conditions in pregnancy can cause both of these events to occur,
which could mean that cNK cells might end up in the ILC1 gate during flow cytometry analysis.
More experiments need to be done to confirm this possibility.
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Figure 3. Ly49A and Ly49D Expression in NK Cell Subsets in Mid-Pregnancy.
Representative flow cytometry plots of Ly49A and Ly49D expression in cNK, trNK, and ILC1
subsets in the spleen, MLAp, and decidua basalis. NK cells were all CD45+CD3-CD19-NK1.1+
and subsets were separated based on expression of eomes and CD49a before analyzing for Ly49
receptor expression. cNK cells defined as eomes+CD49a-, tissue-resident NK cells defined as
eomes+CD49a+, and ILC1’s defined as eomes-CD49a+. Summary data can be found in Table 1.
Table 1. Average Ly49A and Ly49D Receptor Expression in NK Cell Subsets in the Spleen,
Inter-Implantation Sites (”Uterus CTRL”), MLAp, and Decidua Basalis. Virgin and gd9.5
WT B6 female mice were analyzed for their NK cell expression of H2-Dd receptors Ly49A and
Ly49D. The spleen contains primarily cNK cells and therefore trNK and ILC1 were not reported.
Inter-implantation sites, labeled as uterus CTRL indicates undecidualized uterine tissue between
each implantation site in pregnancy. n= 6

CHAPTER FIVE
INTERFERON GAMMA PRODUCTION IN MURINE PREGNANCY
IFNγ release is reduced by Ly49KO NK cells at implantation sites. Interferon gamma
(IFNγ) is a molecule known primarily for its inflammatory effects, as it is released by NK cells
undergoing a pathogenic challenge. However, it has been shown that IFNγ is also released at
implantation sites during pregnancy and aids in spiral artery remodeling. We hypothesized that
signaling through Ly49 receptors may be partially responsible for this IFNγ release, and that
knockout of the receptors may lead to decreased IFNγ release by NK cells at the implantation
sites. Brefeldin A was injected via tail vein into mice at gestational day 9.5 of WT and Ly49KO
female mice 3 hours pre-sacrifice. Any IFNγ produced by NK cells within those 3 hours should
be trapped inside the cell to allow for more accurate analysis for flow cytometry. Tissue from
inter-implantation sites in the uterus was taken as a control since this tissue is not decidualized
and those cells should not be producing as much IFNγ as the cells in the implantation sites. NK
cells at implantation sites make significantly more IFNγ than those in the inter-implantation sites
or in the spleen (Figure 4a, 4b). In addition, less Ly49KO cells at implantation sites produced
IFNγ compared to WT (Figure 4a) and produce less IFNγ per cell (Figure 4b). Conventional NK
cells in Ly49KO mice at implantation sites had a slight reduction in IFNγ output per cell
compared to WT. Still, no other differences were seen between WT and Ly49KO in IFNγ
producing population size or output per cell in the cNK or trNK cell subsets at implantation sites
(Figure 5a-e). The ILC1 subset showed a drastic increase in IFNγ population size and production
per cell in both the WT and Ly49KO cells, but the IFNγ+ population was significantly smaller in
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the Ly49KO ILC1 population compared with the WT ILC1 population. Ly49KO ILC1s also
produced significantly less IFNγ per cell (Figure 5a, f-g).

Figure 4. In Vivo Analysis of IFNγ Production by uNK Cells During Pregnancy gd9.5. WT
B6 and Ly49KO dams were mated with WT B6 sires and injected with BFA at gd9.5 3 hours
before sacrifice. NK cells from the spleens and uteri were analyzed for IFNγ production. Uterus
CTRL indicates undecidualized uterine tissue between each implantation site. NK cells were
gated on CD45+CD3-CD19-NK1.1+.
Ly49KO ILC1s have reduced IFNγ production in MLAp. There are two distinct
anatomical sites at gestational day 9.5, the mesometrial aggregate of pregnancy (MLAp) and
decidua. Since spiral artery remodeling occurs in the decidua and IFNγ production is important
for the process, we hypothesized that the defect in IFNγ production by Ly49KO ILC1s would be
more prevalent in the decidua compared to the MLAp. However, the MLAp showed a significant
reduction in the IFNγ+ population size in Ly49KO ILC1s, while the IFNγ producing ILC1
populations were similar between WT and Ly49KO in the decidua (Figure 6a-b). This could
mean that IFNγ produced in the MLAp moves to the decidua where it is required for spiral artery
remodeling. However, the reason for the reduction in the MLAp is unknown.

45

Figure 5. IFNγ Production from ILC1 cells is Reduced in Ly49KO Dams During
Pregnancy gd9.5. WT B6 and Ly49KO dams were mated with WT B6 sires and injected with
BFA at gd9.5 3 hours before sacrifice. NK cells from the spleens and uteri were analyzed for
IFNγ production. Uterus CTRL indicates undecidualized uterine tissue between each
implantation site. NK cells were gated on CD45+CD3-CD19-NK1.1+ followed by separation of
the uterine subsets using eomes and CD49a. Representative dot plots in (A) of IFNγ production
by eomes+CD49a- cNK cells, eomes+CD49a+ trNK cells, and eomes-CD49a+ ILC1s in total
implantation sites from WT and Ly49KO females. Percentages of IFNγ producing cNK, trNK,
and ILC1 subsets are shown in B,D, and F, respectively. Mean fluorescence Intensity (MFI) of
IFNγ producing cNK, trNK, and ILC1 subsets are shown in C, E, and G, respectively.
Percentage of the uterine NK cell subsets in total implantation site (J), MLAp only (L) and
decidua basalis only (M) in WT and Ly49KO pregnancies. (K) MFI of IFNγ producing cells
from each subset in total implantation sites. n= 6 WT B6 and 5 Ly49KO dams, 4-5 implantation
sites each.
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Ly49D+Ly49A- cells release the most IFNγ. As IFNγ is produced primarily by ILC1s at
implantation sites, we wanted to see whether the IFNγ+ cells expressed Ly49D or Ly49A. The
highest percentage of IFNγ producing cells regardless of subset was Ly49A-Ly49D+ cells. In the
decidua, the cNK cells all were Ly49A+, while the majority of IFNγ+ ILC1s were double
negative for Ly49D and Ly49A. This indicates that signaling via Ly49A and Ly49D may not be
necessary for the decidua for IFNγ production, while it is more critical for the production of
IFNγ in the MLAp via Ly49 signaling (Table 2). This could be the case, as IFNγ production is
only significantly reduced in the Ly49KO in the MLAp and not the decidua.
Table 2. Expression of Ly49A and Ly49D on IFNγ Producing Cells at gd9.5. IFNγ producing
cells from each uNK cell subset in the MLAp (left) and decidua basalis (right) of gd9.5 WT B6
females were analyzed for their expression of H2-Dd receptors Ly49A and Ly49D. n= 4

Figure 6. IFNγ Production from ILC1 Cells is Reduced in Ly49KO Dams in the MLAp and
not the Decidua. WT B6 and Ly49KO dams were mated with WT B6 sires and injected with
BFA at gd9.5 3 hours before sacrifice. NK cells from the spleens and uteri were analyzed for
IFNγ production. Uterus CTRL indicates undecidualized uterine tissue between each
implantation site. NK cells were gated on CD45+CD3-CD19-NK1.1+. n= 6 WT B6 and 5
Ly49KO dams, 4-5 implantation sites each.

CHAPTER SIX
SPIRAL ARTERY REMODELING IN MIDPREGNANCY
Spiral artery remodeling is suboptimal in Ly49KO mice. Since Ly49KO mice have a
defect in IFNγ production in pregnancy in vivo, we aimed to see whether this led to a defect in
spiral artery remodeling. Ashkar et al. (2001) showed that IFNγ production is ideal for spiral
artery remodeling. Confocal imaging of intravascularly labeled CD31 in whole, cleared tissue
allowed for analysis of vessel diameter, area, volume, and straightness. The process of
remodeling creates straightened, dilated vessels to allow for increased blood flow to the fetus.
Images of WT implantation sites compared to a nonpregnant uterus showed visibly wider,
straighter vessels (Figure 7a-b). Ly49KO mated with B6 male showed implantation sites with
somewhat remodeled vessels but to a lesser extent compared to the WT (Figure 7c). Ly49KO
female implantation sites that were mated with D8KODO males showed even more significantly
reduced blood vessel remodeling and looked more similar to the nonpregnant uteri than the
healthy implantation sites (Figure 7d). Quantitation of the remodeling using Imaris 9.7.2
software showed this to be the case, as no significant differences were seen between the
nonpregnant and the Ly49KO x D8KODO implant diameter, volume, or area (Figure 7e, g-h).
The vessels in the Ly49KO x B6 mating were significantly smaller than at the WT implantation
site. They were not as straight (Figure 7b), indicating that these mice have defects in the spiral
artery remodeling process (Figure 7). This defect could be due to the reduced IFNγ production
by the Ly49KO mice compared to WT, but more studies would need to be done to connect the
two defects. MFI of more remodeled vessels was also significantly smaller than insufficiently
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remodeled vessels (Figure 7k). This could be due to the displacement of endothelial cells and
therefore decreased staining for CD31. Therefore, fluorescence intensity could be used to
measure of adequate spiral artery remodeling.
Ly49KO mice have no weight deficiencies in pregnancy or adulthood. Since fetal
weights are decreased in Ly49KO pregnancies at gd 18.5, we hypothesized that this weight
anomaly may continue into adulthood. WT and Ly49KO weights and uterine weights were
tracked through 4 months of age, and no significant difference was found (Figure 8a-b). Ly49KO
implantation sites had no significant reduction in total cell number, NK cell number, or weights
(Figure 8c-m). These findings point towards the decreased fetal weights as a direct result of
suboptimal pregnancy processes instead of root developmental defects.
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Figure 7. Spiral Artery Remodeling in Ly49 KO Dams is Compromised in Pregnancy. WT
virgin, gd9.5 WT B6 and Ly49KO dams mated with B6 sires, and Ly49KO dams mated with
D8KODO sires were injected with APC conjugated CD31 30 minutes before sacrifice. Uterine
tissue and implantation sites were stained ex vivo for smooth muscle actin, then cleared with
Sunjin Labs RapiClear 1.52. Samples were mounted in clearing media and smooth muscle actin
was used to identify the MLAp for imaging of spiral arteries. Representative confocal images
generated of (A) WT nonpregnant uterus control, (B) gd9.5 B6 x B6 implantation site, (C) gd9.5
Ly49KO x B6 implantation site, and (D) gd9.5 LY49KO x D8KODO implantation site.
Quantitation of spiral artery remodeling from whole-mount confocal imaging. Implantation sites
were cleared, mounted, and imaged on a Zeiss confocal microscope. 3D images were analyzed
using Imaris imaging software for vessel diameter (E), straightness (F), area (G), and volume
(H). Area (I) and volume (J) by length intervals were also plotted. Fluorescence intensity (K)
was measured as a possible parameter for spiral artery remodeling sufficiency.
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Figure 8. Adult Ly49KO Females Recover their Weight Deficiency. Weight of whole mice
(A) and uterus (B) of WT and Ly49KO mice from sexual maturity to 4 months of age. Weight of
whole implantation sites (C), MLAp only (D), and decidua basalis only (E) of gd9.5 WT and
Ly49KO dams mated with B6 sires. Total cell count (F), and cell count of gd9.5 total
implantation sites (G), MLAp only (H), and decidua basalis only (I) from WT and Ly49KO
dams. Total NK cell count in nonpregnant uteri (J), gd9.5 whole implantation sites (K), MLAp
only (L), and decidua basalis only (M) from WT and Ly49KO dams. n= 20 virgin WT, 18 virgin
Ly49KO, 12 gd9.5 WT, and 15 gd9.5 Ly49KO females.

CHAPTER SEVEN
IN VITRO STIMULATION OF UTERINE NK CELLS
Rationale for in vitro culture of uterine Natural Killer cells. Natural killer cells have
been analyzed in vitro since their discovery. Such studies focused on cNK cells and their
cytotoxic potential, specifically unsensitized cytotoxicity towards cancer cell lines. Uterine
natural killer cells have a different phenotype and tend to have shorter in vitro lives. We wanted
to set up an in vitro culture system to reduce the complexity of an in vivo model to study Ly49
receptor roles in signaling pathways. Additionally, in vitro manipulation of conditions could
answer whether the phenotype of uNK cells differs due to the environment of the uterus itself,
including cytokines and hormones. Such molecules in high concentrations in the uterus could be
a reason for decreased cytotoxic potential in uNK cells, specifically for trNK cells in the uterus.
In vitro culture would also assist in the analysis of CD49a expression on NK cells in the uterus
when cNK cells are exposed to different hormones.
Ly49KO uterine NK cells respond less to dual stimulation than WT. NK cells are
known for responding to stimulation and becoming activated to exert their cytotoxic potential.
NK1.1 is an activating receptor on all natural killer cells that activates cells when it is engaged.
Plate bound anti-NK1.1 cross-links the receptor and stimulates production of molecules such as
IFNγ and granzymes. In addition, NK cells have been shown to respond to soluble IL-15
stimulation (Hydes et al. 2018) through activation and upregulation of CD49a. We hypothesized
that if Ly49 receptor signaling was necessary for full activation, Ly49KO cells from the spleen
and uterus may respond less than WT cells to anti-NK1.1 and IL-15 stimulation.
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Single cell suspensions of splenic or uterine NK cells were stimulated with plate-bound
anti-NK1.1 and soluble recombinant IL-15 for 6 hours with golgi plug to block release of
cytokines into the supernatant. They were then stained for flow cytometry analysis to analyze
activation levels through IFNγ and granzyme B (GZMB) production. Dual stimulus with IL-15
and anti-NK1.1 caused a significant decrease in the IFNγ+ uNK cells from the Ly49KO mouse,
but not in GZMB+ population size or amount produced per cell of IFNγ or GZMB (Figure 9a-d).
Stimulation with anti-NK1.1 or recombinant IL-15 alone caused no significant differences
between WT and Ly49KO NK cell activation in the uterus. No differences were seen in the
splenic NK cells in any stimulation conditions.

Figure 9. Interferon Gamma and Granzyme B Production by in Vitro Stimulated NK Cells.
Single cell suspensions from the spleen and uterus of WT B6 and Ly49KO females. Cells were
stimulated with plate-bound αNK1.1, soluble rIL-15, or both for 6 hours. Cultures were
harvested and analyzed via flow cytometry for IFNγ and GZMB production. Cells were gated on
live, CD45+CD3-CD19-NK1.1+ cells. Percentage (A) and MFI (B) of IFNγ production from
stimulated NK cells. Percentage (C) and MFI (D) of GZMB production from stimulated NK
cells.
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The notion that IL-15 and anti-NK1.1 stimulation cause a defect in Ly49KO cells in the
uterus to become fully activated points to a possible missed third signal. Since the stimulation
was performed on total lymphocytes from the uterus, we hypothesize that another cell in the
culture may have been stimulated as well to release factors that then would activate the cells
through Ly49 receptors. Since the Ly49KO mice do not have such receptors, they may be
missing the third signal necessary for complete activation of the cells such as the WT. More
studies, such as a cytokine capture assay, need to be done to confirm this. Since not all ligands
for Ly49 receptors are known, it is possible that cytokines released from the total lymphocyte
population in the culture could give clues as to possible ligands for Ly49 receptors as well.
Hormone stimulation causes a change in NK cell subsets in the uterus. Due to the
notion that NK cell subsets could change their profile in response to hormones, we hypothesized
that stimulation using soluble hormones in vitro could cause changes in eomes and/or CD49a
expression. However, most culture media contains hormones due to the serum. We used charcoal
stripped FBS for the culture to strip the NK cells from any possible hormone stimulation for
three consecutive days in low dose IL-15 to keep the cells alive. This was followed by culture in
either estrogen, progesterone, both, or neither for 6 hours and analyzed via flow cytometry for
eomes and CD49a expression. Splenic NK cells ex vivo showed that most of the cells were
conventional NK cells. After hormone stripping and stimulation, very little change was seen in
the population percentages of NK cells besides an increase in CD49a expression shown by an
increase in the trNK population size (Figure 10a). The uterine NK cells involved a similar
percentage of cNK and trNK ex vivo, but after hormone stripping, showed various population
size changes depending on the stimulation. All stimulation showed an increase in the ILC1
population size, indicating a possible downregulation of eomes. The largest increase in the ILC1
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population was with the IL-15 stimulation (Figure 10b). The large ILC1 population may indicate
that the cells were continuously stimulated with IL-15 since it was in the culture with the
hormone stripped media, followed by a high dose of IL-15, causing the cells to downregulate
eomes. Another hypothesis for this change could be that hormones are necessary to keep eomes
expressed in uterine NK cells, so the lack of hormone for three days decreased the expression.
Six hours may not have been enough to restore the levels of eomes back to the unstimulated
amounts. More studies would need to be done to see whether hormones are necessary for high
expression of eomes.

Figure 10. Stimulation of NK Cells with Exogenous Hormones. cNK (eomes+CD49a-), trNK
cells (eomes+CD49a+), and ILC1s (eomes-CD49a+) from the spleen (A) and the uterus (B) were
analyzed before being stripped of hormones and cultured with exogenous E2, P4, both, or IL-15.
Cells were analyzed for change in population size. Percentage of IFNγ (C) and GZMB (D)
production by the total NK cell populations after stimulation with exogenous hormones.
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Hormone stimulation causes NK cells to become activated. Since NK cells respond to
hormones in various conditions, including pregnancy, we hypothesized that after stripping
hormones from the cells and adding exogenous hormones for six hours, NK cells may respond
through cytokine release. NK cells were analyzed by flow cytometry for their production of IFNγ
and GZMB. Both splenic and uterine NK cells responded to hormone stimulation through release
of IFNγ, with the highest change in the uterus being combined E2 and P4 stimulation. Splenic
NK cells responded through GZMB production, but uterine NK cells had no significant changes
in GZMB production upon stimulation (Figure 10c-d). These results indicate that uNK cells
could be programmed differently due to the uterine environment and are less likely to release
cytotoxic granzymes when stimulated with hormones than splenic NK cells. The signals in the
uterus that could reduce this cytotoxic potential are still unknown.

CHAPTER EIGHT
APPENDIX
Synchronization of the estrous cycle. Analysis of virgin mice poses a problem due to
the changes that occurs during the estrus cycle. NK cell subsets change throughout the cycle,
with cNK and trNK predominating the estrus and diestrus stages, respectively. It is crucial that
mice are age-matched and stage-matched when analyzing NK cells from a virgin uterus and
comparing between mice to minimize any factors that might impact results. We hypothesized
that hormones throughout the estrous cycle are partially responsible for the shift in NK
populations and that intraperitoneal injections of estrogen or progesterone could synchronize
mice into the same stage. We found that estradiol injections for 2 or 3 days before sacrifice was
able to shift NK cell subsets to the same percentages as in natural estrus, while 3 injections of
progesterone shifted NK cell subsets to a similar profile as natural diestrus (Figure 11a). Weights
of the uteri did not significantly differ between the different injection conditions (Figure 11b),
ensuring that the injections did not cause drastic changes to the uterus. Results were consistent
regardless of the stage that the mice were in for the initial injection. Mice were not analyzed to
see if the synchronization beyond the injections was long-lasting. Such an experiment would be
necessary to see whether the synchronization continued after the injected hormones wore off.
This method could be used to synchronize mice into the same stage of the estrous cycle. NK cell
activation may
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be increased due to the excess hormones, so an in-depth analysis of the NK cell function is
necessary before doing further research on synchronized mice.

Figure 11. Synchronization of the Murine Estrous Cycle. Virgin, sexually mature female
mice were injected every 24 hours with either estradiol or progesterone for 2 or 3 days. (A)
Percentages of cNK, trNK, and ILC1s in natural estrus, with 2 or 3 estradiol injections, or 3
progesterone injections. (B) Weights of virgin uteri after injections compared to natural estrus
uteri. N=2-4 mice for each condition.

Figure 12. NFIL3 Deficient Mice have Uterine trNK and ILC1s that Express Ly49
Receptors. Expression levels of Ly49A (A) and Ly49D (B) on the uterine trNK (light blue) and
ILC1s (dark blue) in NFIL3 deficient virgin mice.
Conventional NK cells are not the only source of tissue resident NK cells or ILC1s in
the Uterus. To partially address the question of whether ILC1s at implantation sites are cNK
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cells that have been continuously stimulated and in the presence of IL-15 to upregulate CD49a
and downregulate eomes, we used an NFIL3-/- model. This mouse model does not have the
transcription factor NFIL3, which is required for the development of conventional NK cells. As
such, NFIL3-/- mice do not have cNK cells but do have uterine ILC1s and trNK cells. We
hypothesized that if cNK cells give rise to trNK or ILC1s in the uterus, that trNK and ILC1
populations in the NFIL3KO uterus may not have Ly49 receptors. Tissue resident NK cells and
ILC1s both contain Ly49D and Ly49A on the surface (Figure 12), which indicates that there is
more than one developmental pathway for NK-like cells in the uterus. The presence alone of
trNK cells and ILC1s in these mice indicates this notion. It remains that NFIL3-/- mice have
defects in spiral artery remodeling and decreased birth weights, meaning that cNK cells are
necessary for such processes. The hypothesis of cNK falling into the ILC1 gate during pregnancy
has yet to be determined.

CHAPTER NINE
DISCUSSION
Natural killer cells differ between organs in their cytotoxic function and overall
phenotype. The uterus poses a unique environment in which the cells are exposed to allogenic,
fetally derived cells that the maternal immune system must tolerate for a healthy pregnancy to
result. NK cells have been studied in the uterus for their ability to aid in pregnancy-induced
processes due to their high prevalence in early-to-mid pregnancy. Our data shows that uterine
NK cells in pregnancy have an alternative phenotype compared to cNK cells in the spleen and in
circulation. Uterine NK cells respond to hormones found in pregnancy through changes in their
phenotypes that allow them to produce factors important for spiral artery remodeling. These
studies also show that Ly49 receptors found on the surface of NK cells are necessary for optimal
spiral artery remodeling, a process for which NK cells and their secreted IFNγ are important.
Ly49KO mice have reduced fetal weights when mated with B6 sires and specifically
when mated with males that have transgenic MHC-I molecules. However, Ly49KO adult mice
resulting from Ly49KO x Ly49KO matings have no defect in weights compared to adult B6
mice. This finding shows that pregnancy-associated processes are affected by Ly49/MHC-I
interactions, but the loss of Ly49 receptors does not affect the gross health of adult mice. Our
data implicates an importance for Ly49/MHC-I interactions in pregnancy. We sought to
understand the processes these interactions are important for during pregnancy. While Ly49KO
uNK cells mature normally like WT uNK cells, they have defects in IFNγ production both when
stimulated in vitro and in vivo at gd9.5 compared to WT controls. This was especially prevalent
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in the ILC1 subset, which unexpectedly produced the most IFNγ overall compared to cNK and
trNK in the uterus. Additionally, a smaller subset of Ly49KO ILC1s produced IFNγ in the
MLAp compared to WT, but not the decidua basalis. The defect in IFNγ production was
accompanied by a visible reduction in spiral artery remodeling. This reduction was quantified by
spiral artery diameter, straightness, area, and volume, all of which were reduced in Ly49KO
pregnancies. Results were exacerbated by Ly49KO mating with D8KODO males, further
clarifying the importance of Ly49/MHC-I interaction for allowing adequate spiral artery
remodeling. Since Ly49KO maternal NK cells have no Ly49 receptors to interact with the
transgenic MHC-I molecule on D8KODO-derived trophoblast cells, we hypothesize that other
mechanisms may be at play that produce this exacerbated phenotype. One such possibility is the
various T cell populations at the maternal-fetal interface, which could recognize the H2-Dd as
non-self. Effector T cells have been shown to induce pregnancy complications if they are present
at the maternal-fetal interface (Ernerudh et al. 2011). Additionally, a mismatch of mother/child
HLA molecules in human studies showed an enriched population of CD4 T cells (Tilburgs et al.
2009). Such enrichment due to the allogeneic MHC-I molecule in D8KODO studs could lead to
signaling changes that leads to reduced spiral artery remodeling in these Ly49KO dams.
However, more studies are necessary to accomplish the link between CD4 T cell population
enrichment with mismatched MHC-I molecules and pregnancy outcomes.
We noted that ILC1s were the uNK cell subset producing the most IFNγ in vivo at gd9.5.
This finding was unexpected, as the literature points towards cNK or trNK cells being the IFNγ
producing population in pregnancy (Ashkar et al. 2000, Depierreux et al. 2021). There are two
possible explanations for this finding: first, previous studies have not captured IFNγ in vivo, but
analyzed production after in vitro stimulation via NK1.1 cross-linking (Depierreaux et al. 2021).
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Such stimulation will activate NK cells that may not have been activated in vivo. It does not
provide an accurate analysis of which cells assist in spiral artery remodeling through IFNγ
production in the implantation site itself. This means that cNK and trNK still have the potential
to produce IFNγ at the maternal/fetal interface, while our findings suggest that they do not exert
this potential unless stimulated in vitro.
The second hypothesis to explain this phenomenon is that conventional NK cells fall into
the ILC1 gate in pregnancy when analyzed via flow cytometry. Studies have shown that when
cNK are continuously stimulated, they downregulate eomes (Gill et al. 2012, Park et al. 2019,
Gao et al. 2017). The conditions in pregnancy may create an environment where cNK are being
stimulated in this way, causing them to downregulate their eomes expression. IL-15 produced by
trophoblast cells in the implantation site may cause the same cells to increase their CD49a
expression. This is a possibility as our data shows IL-15 stimulation can alter CD49a expression.
Such events could cause true cNK cells to fall into the ILC1 gate in flow cytometry analysis.
Additional support for this hypothesis comes in the fact that we noted a high percentage of ILC1s
when uterine NK cells were stimulated with exogenous hormones. Similarly, this may have
caused cNK cells to be overly-stimulated and downregulate their eomes production. IL-15 was
also in the culture and has been shown to cause upregulation of CD49a on NK cells (Hydes et al.
2018). Ly49A and Ly49D receptor expression is not altered on cNK cells at implantation sites,
while ILC1s shift towards higher amounts of Ly49A expression. This expression profile mimics
that of cNK cells, and provides additional evidence for this hypothesis. Overall, our data is
additional evidence that this phenomenon may be occurring in pregnancy.
NFIL3KO mice, which lack cNK cells but not uterine trNK or ILC1, also have defects in
spiral artery remodeling and provide further evidence that the presence of cNK at the
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implantation site could be necessary for adequate IFNγ production (Boulenouar et al. 2016). Our
studies show that NFIL3KO trNK and ILC1s still contain Ly49 receptors, but any possible cNK
cells that have upregulated CD49a or downregulated Eomes are not present. It could be that such
transformed cells are the true IFNγ-producing cells at implantation sites. Studies involving
transfer of congenically marked cells to track how their expression of CD49a and eomes changes
in pregnancy would need to be done to confirm this. RNA-sequencing of the uNK cell subsets in
virgin vs pregnant mice at gd9.5 may also give some clues towards the plasticity of these cells
and transcript levels of IFNγ.
Ly49KO mice have defects both in IFNγ production and spiral artery remodeling
compared to WT mice. Studies by Ashkar et al. showed a connection between the presence of
IFNγ at the maternal-fetal interface and productivity of spiral artery remodeling (Ashkar et al.
2000). They found that lack of NK cell-derived IFNγ reduced spiral artery remodeling. However,
the mechanisms for IFNγ-mediated spiral artery remodeling are still unknown. Endothelial cells
contain IFNγ receptor, so it is possible that NK cell-derived IFNγ signals directly to the
endothelial cells (Cencic et al. 2003). Additionally, IFNγ is an important macrophage activation
molecule. Macrophages at the maternal-fetal interface in mice have been implicated in the
process of spiral artery remodeling through production of matrix metalloproteases (MMPs),
factors important for stimulating spiral artery remodeling and are found in close proximity to the
vessels at the maternal-fetal interface (Kaitu’u et al. 2005, Fontana et al. 2012). It is also likely
that IFNγ signals in an autocrine fashion to uNK cells to stimulate the secretion of proangiogenic factors such as VEGF-A, HIF1A, and angiogenin, which mediate the alteration of
blood vessels for efficient remodeling (Hoeres et al. 2018, Li et al. 2001). This points towards a
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high importance for Ly49 receptor interaction with MHC-I at the maternal-fetal interface.
However, the role of Ly49 receptor signaling in such connections remains unknown.
Allogenic males and Ly49KO females with B6 mating partners cause reduced fetal
weights, and the effects are heightened when both scenarios are combined. The signaling cascade
through Ly49 receptors that leads to IFNγ signaling is still unknown. Additionally, not all
ligands of Ly49 receptors are known, so the lack of receptors may be inhibiting cytokine
interactions with the Ly49 receptors in addition to interactions between Ly49 receptor and MHCI. One possible molecule that could signal to Ly49 receptors is alpha-2-macroglobulin, which has
been shown to be a molecule important for artery remodeling in human pregnancy as a response
to IFNγ signaling (Tayade et al. 2005). More studies will need to be done to examine NK cell
ligands. Once more ligands are identified, analysis of stimulation of whole leukocytes from the
uterus can be done to determine if such factors are produced under the stimulation of IL-15 and
anti-NK1.1.
Pregnancy and the exposure to foreign MHC-I molecules is an environment where NK
cells must tolerate non-self. Our studies indicate that uNK cells found in the MLAp and decidua
in pregnancy differ from cNK cells found in the spleen. These cells have different maturation
profiles, altered Ly49 expression, and respond to hormone stimulation. Such findings indicate
that the tissue in which NK cells are located is important for their phenotype and potentially their
function.
Some studies have shown that the vascular endothelium is displaced during spiral artery
remodeling (Ashton et al. 2004, Bulmer et al. 2020). This could lead to decreased staining
intensity in fully remodeled vessels. We hypothesized that potentially the mean fluorescence of
the WT implantation site vessels would have the least amount of fluorescence in our confocal
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imaging experiments and could lead to a possible measure of spiral artery remodeling success.
Overall, the WT implantation site had the least fluorescence and the Ly49KO x D8KODO
implant had the most intense staining. This implicates that potentially the endothelium is
displaced when the vessel is remodeled, leaving less CD31 to be stained when vessels are fully
remodeled and therefore reduced staining intensity.
Ly49 receptors and their interactions with MHC-I molecules are proven to be important
for NK cell function. Past studies have proven this notion specifically in terms of cancer and
viral infection. However, the importance for these interactions in pregnancy has still not yet been
fully characterized. Paternal MHC-I expression on fetally-derived EVTs poses a unique scenario
for NK cells at the maternal/fetal interface where they must tolerate foreign MHC that is of nonself. Such NK cells are able to exert their cytotoxic potential against viral targets while
maintaining their tolerance towards EVTs expressing the foreign MHC. This indicates that the
missing-self hypothesis is altered in the uterine tissue specifically in pregnancy, most likely
controlled by the Ly49 receptor expression on these cells compared to circulating NK cells. The
environment of the uterus may be important for altering phenotypes of the NK cells, including
changes in expression levels of eomes and CD49a. Since Ly49KO mice have defects in IFNγ
production at implantation sites, specifically in the MLAp, as well as suboptimal spiral artery
remodeling, Ly49 receptors most likely help mediate the change in phenotype of uNK cells
specifically in pregnancy.
In conclusion, we found that Ly49 receptors are necessary for carrying out NK-mediated
functions in pregnancy. Whilst the missing-self hypothesis is modified in pregnancy, it is still
unknown how the missing-self hypothesis is regulated to change uNK cell function. We
hypothesized that Ly49 receptors would mediate signaling to uNK cells necessary for IFNγ
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release and spiral artery remodeling in pregnancy. IFNγ production is reduced in Ly49KO mice
at implantation sites, specifically in the ILC1 subset. This finding indicates that Ly49 receptor
signaling is necessary for producing adequate amounts of IFNγ at the implantation site.
Additionally, since IFNγ production is important for spiral artery remodeling, we sought to
analyze extent of arterial remodeling in Ly49KO pregnancies. The implantation sites of Ly49KO
mice had reduced arterial diameter, area, volume, and straightness compared to WT controls,
suggesting that Ly49 receptors are important for NK cell-mediation of spiral artery remodeling.
Overall, our results show the necessity for integrating activating and inhibitory signals by Ly49
receptors for adequate NK cell activity at the maternal-fetal interface.
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